<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Anesthesia for aortic surgery with hypothermia and elective circulatory arrest in adult patients
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Anesthesia for aortic surgery with hypothermia and elective circulatory arrest in adult patients
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Anesthesia for aortic surgery with hypothermia and elective circulatory arrest in adult patients
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Albert T Cheung, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michele Heath, LP, CCP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jonathan B Mark, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nancy A Nussmeier, MD, FAHA
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kathryn A Collins, MD, PhD, FACS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 04, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H3417729635">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Open surgical repair of the ascending aorta or aortic arch requires temporary interruption of cerebral and systemic blood flow [
         <a href="#rid1">
          1,2
         </a>
         ]. Deliberate circulatory arrest is induced with the aid of cardiopulmonary bypass (CPB) to allow surgical replacement of the ascending aorta or aortic arch, and hypothermia helps protect vital organs from ischemia during the period of elective circulatory arrest. This topic discusses anesthetic management and strategies for cerebral protection during proximal aortic surgery with deep hypothermic circulatory arrest (DHCA).
        </p>
        <p>
         Preparations for, management of, and weaning from CPB are discussed in separate topics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/115759.html" rel="external">
          "Initiation of cardiopulmonary bypass"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">
          "Management of cardiopulmonary bypass"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/90614.html" rel="external">
          "Weaning from cardiopulmonary bypass"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Surgical indications and techniques to accomplish repairs of the ascending aorta and aortic arch are reviewed in other topics. (See
         <a class="medical medical_review" href="/z/d/html/88951.html" rel="external">
          "Overview of open surgical repair of the thoracic aorta", section on 'Ascending aorta'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/88951.html" rel="external">
          "Overview of open surgical repair of the thoracic aorta", section on 'Aortic arch'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H346374505">
         <span class="h1">
          PREANESTHETIC ASSESSMENT AND PLANNING
         </span>
         <span class="headingEndMark">
          —
         </span>
         General considerations for preanesthetic consultation before cardiac surgical procedures are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/94291.html" rel="external">
          "Preoperative evaluation for anesthesia for cardiac surgery"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3532591522">
         <span class="h2">
          Coexisting pathology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with acute or chronic disease of the ascending aorta or arch have coexisting conditions that may affect anesthetic and surgical management, as described below. (See
         <a class="medical medical_review" href="/z/d/html/88951.html" rel="external">
          "Overview of open surgical repair of the thoracic aorta", section on 'Preoperative evaluation and preparation'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Aortic regurgitation
         </strong>
         – Aortic regurgitation (AR; also called aortic insufficiency) may be present due to a dilated aortic root or dissection that involves the aortic root. This condition is often associated with signs and symptoms of heart failure. Diagnosis with preoperative transthoracic or transesophageal echocardiography (TEE) is confirmed by intraoperative TEE examination during the prebypass period. (See
         <a class="local">
          'Transesophageal echocardiography'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Modifications in cardioplegia delivery technique and/or left ventricular (LV) venting during cardiopulmonary bypass (CPB) may be necessary if significant AR is present, as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/130764.html" rel="external">
          "Management of special populations during cardiac surgery with cardiopulmonary bypass", section on 'Aortic regurgitation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Atherosclerotic disease
         </strong>
         – Severe thoracic aortic atherosclerosis or carotid artery disease that increases the risk of cerebral and systemic thromboembolic complications may be present. Also, the presence of significant occlusive cerebrovascular disease may lead to choosing selective antegrade cerebral perfusion (SACP) rather than retrograde cerebral perfusion (RCP), as discussed below. (See
         <a class="local">
          'Selective cerebral perfusion during DHCA'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mediastinal mass effect
         </strong>
         – Some patients have a mediastinal mass effect due to compression of the right ventricular outflow track, trachea, right pulmonary artery, or left mainstem bronchus by a large ascending aortic aneurysm  (
         <a class="graphic graphic_diagnosticimage graphicRef108358" href="/z/d/graphic/108358.html" rel="external">
          image 1
         </a>
         ) [
         <a href="#rid3">
          3-6
         </a>
         ]. This may result in hemodynamic or airway compromise during induction. Details are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/94259.html" rel="external">
          "Anesthesia for patients with an anterior mediastinal mass", section on 'Airway management during induction'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94259.html" rel="external">
          "Anesthesia for patients with an anterior mediastinal mass", section on 'Hemodynamic management during induction'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1605849470">
         <span class="h2">
          Review of the surgical plan
         </span>
         <span class="headingEndMark">
          —
         </span>
         Planned cerebral protection strategies during elective circulatory arrest are reviewed with the surgical team; these are institution- and surgeon-specific [
         <a href="#rid1">
          1,7
         </a>
         ]. Most cases of planned circulatory arrest are performed with either moderately deep hypothermia (in the range of 20 to 28 °C) or deep hypothermia (in the range of 16 to 20°C) [
         <a href="#rid8">
          8,9
         </a>
         ], usually supplemented with SACP or RCP [
         <a href="#rid10">
          10-13
         </a>
         ]. (See
         <a class="local">
          'Selective antegrade cerebral perfusion'
         </a>
         below and
         <a class="local">
          'Retrograde cerebral perfusion'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2964528604">
         <span class="h3">
          Planned use of moderately deep or deep hypothermia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Surgical replacement of the ascending aorta or aortic arch requires temporary interruption of cerebral and systemic blood flow. Inducing moderately deep or deep hypothermia with the aid of CPB permits surgical reconstruction of the aortic arch without cross clamping a diseased aorta or instrumenting and possibly injuring aortic arch branch vessels. Multiple temperature monitoring sites and specialized brain monitors are used before, during, and after a period of deep hypothermia. (See
         <a class="local">
          'Temperature monitors'
         </a>
         below and
         <a class="local">
          'Brain monitors'
         </a>
         below.)
        </p>
        <p>
         Moderately deep or deep hypothermia cause physiologic changes that can persist  (
         <a class="graphic graphic_table graphicRef109339" href="/z/d/graphic/109339.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid14">
          14-16
         </a>
         ]. (See
         <a class="local">
          'Considerations for anesthetic management'
         </a>
         below and
         <a class="local">
          'Problems in the postbypass period'
         </a>
         below.)
        </p>
        <p>
         Preparations include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Since coagulopathy with persistent bleeding is common, adequate venous access is necessary. Typically, four to six units each of red blood cells (RBCs) and fresh frozen plasma (FFP) are crossmatched, as well as four to six pooled whole blood-derived platelet concentrates (or one apheresis unit).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vasoconstriction typically occurs during cooling and hypothermia, while vasodilation typically occurs during rewarming and reperfusion. Vasoactive infusions are prepared in advance to treat blood pressure that is either too high or too low  (
         <a class="graphic graphic_table graphicRef119750" href="/z/d/graphic/119750.html" rel="external">
          table 2
         </a>
         and
         <a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="local">
          'Control of blood pressure'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Since nearly all patients undergoing moderately deep or deep hypothermic circulatory arrest (DHCA) develop hyperglycemia requiring control with intravenous (IV) insulin administration, an insulin infusion is prepared.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2681694913">
         <span class="h3">
          Planned use of selective cerebral perfusion techniques
         </span>
         <span class="headingEndMark">
          —
         </span>
         DHCA is often combined with SACP or RCP. Plans for selective cerebral perfusion guide selection of site(s) to monitor direct arterial pressure. (See
         <a class="local">
          'Intra-arterial catheter'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1896930728">
         <span class="h2">
          Considerations for emergency surgery for acute aortic dissection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Emergency surgical repair is necessary for acute ascending (type A) aortic dissection  (
         <a class="graphic graphic_movie graphicRef99346" href="/z/d/graphic/99346.html" rel="external">
          movie 1
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef108394" href="/z/d/graphic/108394.html" rel="external">
          image 2
         </a>
         and
         <a class="graphic graphic_figure graphicRef100115" href="/z/d/graphic/100115.html" rel="external">
          figure 1
         </a>
         ). Surgical and preanesthetic evaluation and preparation are expedited so that induction of general anesthesia can proceed without delay [
         <a href="#rid7">
          7
         </a>
         ]. Risk of mortality due to complications (eg, acute aortic regurgitation, cardiac tamponade, stroke, myocardial infarction) is estimated to be as high as 1 to 2 percent per hour after symptom onset.
        </p>
        <p>
         Factors that increase risk and affect anesthetic and surgical management include [
         <a href="#rid7">
          7,17
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute AR
         </strong>
         – Acute AR may occur as a consequence of dissection involving the aortic root. Patients with acute AR typically present with tachycardia and decompensated heart failure due to a sudden increase in LV diastolic pressure. Beta-blocker therapy to control heart rate (HR) or blood pressure (BP) is withheld or administered cautiously to prevent cardiogenic shock in a patient with acute AR.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Additional considerations for patients with significant AR are applicable during CPB. (See
         <a class="medical medical_review" href="/z/d/html/130764.html" rel="external">
          "Management of special populations during cardiac surgery with cardiopulmonary bypass", section on 'Aortic regurgitation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardiac tamponade
         </strong>
         – Cardiac tamponade is a common complication of Stanford type A aortic dissection  (
         <a class="graphic graphic_figure graphicRef100115" href="/z/d/graphic/100115.html" rel="external">
          figure 1
         </a>
         ). The aortic root and the first 11 cm of the ascending aorta lie within the pericardial sac; thus, a contained rupture of the aortic root or proximal ascending aorta may result in hemopericardium with tamponade. Signs of cardiac tamponade on physical examination should be noted. Presence of blood in the pericardial space on the preoperative computed tomography (CT) scan or echocardiogram or signs of cardiac tamponade on physical examination should be noted. Severity of cardiac tamponade is assessed with preoperative transthoracic echocardiography (TTE) but may worsen during preoperative evaluation. Thus, severity is reassessed with intraoperative TEE after induction of general anesthesia. (See
         <a class="medical medical_review" href="/z/d/html/114422.html" rel="external">
          "Anesthesia for patients with pericardial disease and/or cardiac tamponade", section on 'Assessing diagnostic tests'
         </a>
         and
         <a class="local">
          'Transesophageal echocardiography'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         As noted above for patients with acute AR, beta-blocker therapy is withheld in a patient with cardiac tamponade to prevent cardiogenic shock.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Malperfusion of extremities
         </strong>
         – Aortic branch vessels involved in the dissection or perfused from the false lumen of the aorta may result in limb malperfusion that determines which sites are suitable for intra-arterial catheter insertion for continuous monitoring of BP (see
         <a class="local">
          'Intra-arterial catheter'
         </a>
         below), as well as for arterial cannulation for CPB. Malperfusion may manifest as a pulse deficit on physical examination or be noted as decreased flow on the arterial phase of the preoperative CT angiogram.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute stroke
         </strong>
         – Malperfusion or dissection of the aortic arch vessels may cause an acute stroke [
         <a href="#rid18">
          18
         </a>
         ]. Preoperative or intraoperative surface vascular ultrasound or carotid artery duplex imaging may be used to diagnose extension of the dissection into the common carotid arteries and to assess blood flow in these arteries.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute coronary syndrome
         </strong>
         – Acute coronary syndrome may occur due to coronary dissection or malperfusion, with consequent onset of myocardial infarction or ventricular failure. Severe preoperative LV dysfunction is a predictor of mortality [
         <a href="#rid19">
          19
         </a>
         ]; management is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/115472.html" rel="external">
          "Intraoperative problems after cardiopulmonary bypass", section on 'Left ventricular dysfunction'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute mesenteric ischemia
         </strong>
         – Acute visceral ischemia may manifest as acute renal failure or abdominal pain with melena. Renal risk mitigation during cardiac surgery is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/130764.html" rel="external">
          "Management of special populations during cardiac surgery with cardiopulmonary bypass", section on 'Chronic kidney disease and renal risk mitigation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute spinal cord ischemia
         </strong>
         – Rarely, aortic intramural hematoma may cause spinal cord ischemia with paraparesis/paraplegia [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Coagulopathy
         </strong>
         – Acute type A aortic dissection is associated with preoperative coagulopathy that worsens during and after surgery, particularly if deep hypothermia is used [
         <a href="#rid21">
          21
         </a>
         ]. (See
         <a class="local">
          'Control of coagulopathy to achieve hemostasis'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H346374511">
         <span class="h1">
          MONITORING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Usual monitoring for cardiac surgery with cardiopulmonary bypass (CPB) is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/126473.html" rel="external">
          "Anesthesia for cardiac surgery: General principles", section on 'Monitoring'
         </a>
         .)
        </p>
        <p>
         Monitoring considerations specific to aortic surgery with deep hypothermia and elective circulatory arrest (DHCA) are noted below [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H230752964">
         <span class="h2">
          Intra-arterial catheter
         </span>
         <span class="headingEndMark">
          —
         </span>
         An intra-arterial catheter is typically inserted in an upper extremity prior to induction and is used for continuous monitoring of arterial blood pressure (BP), analysis of respirophasic variations in the arterial pressure waveform, and intermittent blood sampling for intraoperative laboratory tests. (See
         <a class="medical medical_review" href="/z/d/html/8174.html" rel="external">
          "Intra-arterial catheterization for invasive monitoring: Indications, insertion techniques, and interpretation", section on 'Uses'
         </a>
         .)
        </p>
        <p>
         For patients with pathology of the ascending aorta and aortic arch, selection of the intra-arterial cannulation site is affected by the likely accuracy of BP measurements or the presence of malperfusion in each upper extremity. Examples include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In most cases, arterial catheters are placed in both upper extremities to optimally estimate central aortic BP and cerebral perfusion pressure (CPP) during various phases of the operation. For example, during delivery of selective antegrade cerebral perfusion (SACP) (see
         <a class="local">
          'Selective antegrade cerebral perfusion'
         </a>
         below), BP measured from the right radial artery provides the best estimate of CPP. However, during right axillary artery cannulation for delivery of SACP, continuous measurement of right radial arterial BP will be temporarily interrupted, necessitating BP measurements in the left arm only.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If the surgical procedure involves reconstruction of the distal aortic arch, the left subclavian artery may be temporarily occluded or interrupted. In such cases, a right radial catheter provides the most accurate monitor of systemic BP.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If an aortic dissection extends into an aortic arch branch vessel or involves the innominate or subclavian arteries  (
         <a class="graphic graphic_figure graphicRef100115" href="/z/d/graphic/100115.html" rel="external">
          figure 1
         </a>
         ), malperfusion of one or more extremities may occur. This complication of upper extremity malperfusion manifests as a pulse deficit in one or both arms. In such cases, arterial catheters are placed in both upper extremities to measure the arterial pressure differential to estimate the severity of malperfusion. However, estimates of systemic BP are derived from measurements in the limb with the higher BP. Normalization of the arterial pressures in the upper extremities after surgery indicates a successful repair.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2868326478">
         <span class="h2">
          Pulmonary artery catheter
         </span>
         <span class="headingEndMark">
          —
         </span>
         A large-bore central venous catheter (CVC) is necessary to permit rapid administration of blood products, as well as provide central vascular access for the infusion of vasoactive agents. We use an introducer sheath (eg, Cordis) that functions as a large-caliber CVC and as a means to place a pulmonary artery catheter (PAC).
        </p>
        <p>
         We typically use a PAC catheter to monitor pulmonary arterial pressure (PAP), central venous pressure (CVP), cardiac output (CO), and mixed venous oxygen saturation (SvO
         <sub>
          2
         </sub>
         ) throughout the prebypass and postbypass periods. These values are useful for guiding vasopressor and inotropic administration, as well as for monitoring responses to intraoperative fluid and blood administration. Also, an increase in the PAP may indicate left ventricular (LV) distention due to aortic regurgitation (AR); this may be noticed during initiation of CPB or infusion of antegrade cardioplegia. (See
         <a class="medical medical_review" href="/z/d/html/130764.html" rel="external">
          "Management of special populations during cardiac surgery with cardiopulmonary bypass", section on 'Aortic regurgitation'
         </a>
         .)
        </p>
        <p>
         In the intensive care unit (ICU), continued monitoring of PAC, CVP, and CO values remains useful after major thoracic aortic surgery to detect problems such as severe LV dysfunction or cardiac tamponade caused by persistent bleeding. Also, residual lactic acidosis is common following reperfusion after DHCA; measurements of CO and SvO2 obtained via the PAC aid in circulatory management in the postoperative period.
        </p>
        <p class="headingAnchor" id="H2926677545">
         <span class="h2">
          Transesophageal echocardiography
         </span>
         <span class="headingEndMark">
          —
         </span>
         Typical uses of transesophageal echocardiography (TEE) during cardiac surgery are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/126473.html" rel="external">
          "Anesthesia for cardiac surgery: General principles", section on 'Transesophageal echocardiography'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/126473.html" rel="external">
          "Anesthesia for cardiac surgery: General principles", section on 'Postbypass transesophageal echocardiography'
         </a>
         .)
        </p>
        <p>
         We agree with practice guidelines regarding use of intraoperative TEE during thoracic aortic surgery published by the American College of Cardiology/American Heart Association (ACC/AHA) [
         <a href="#rid1">
          1
         </a>
         ], the American Society of Anesthesiologists (ASA) [
         <a href="#rid22">
          22
         </a>
         ], and the Society of Cardiovascular Anesthesiologists (SCA) [
         <a href="#rid1">
          1,22
         </a>
         ]. In a matched cohort study of 872,936 patients in the Society of Thoracic Surgeons (STS) database, intraoperative TEE was associated with lower 30-day mortality after proximal aortic surgery compared with not using TEE (3.81 versus 5.27 percent; odds ratio [OR] 0.69, 95% CI 0.67-0.72) [
         <a href="#rid23">
          23
         </a>
         ]. Composite outcomes were also lower (ie, stroke or 30-day mortality; reoperation or 30-day mortality). Specific uses in this setting include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prebypass period
         </strong>
         – In addition to standard examination, TEE is used to confirm and characterize the extent of aortic pathology [
         <a href="#rid7">
          7
         </a>
         ]. The aortic valve is examined to determine if there is significant AR and to quantify its severity  (
         <a class="graphic graphic_movie graphicRef54254" href="/z/d/graphic/54254.html" rel="external">
          movie 2
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef79069" href="/z/d/graphic/79069.html" rel="external">
          image 3
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef106988" href="/z/d/graphic/106988.html" rel="external">
          image 4
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef106998" href="/z/d/graphic/106998.html" rel="external">
          image 5
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In emergency surgery for type A aortic dissection, intraoperative TEE examination is used to diagnose the extent and classification of the dissection  (
         <a class="graphic graphic_movie graphicRef99346" href="/z/d/graphic/99346.html" rel="external">
          movie 1
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef108394" href="/z/d/graphic/108394.html" rel="external">
          image 2
         </a>
         ), particularly if hemodynamic instability necessitates initiation of surgery without computed tomographic angiography (CTA) images. TEE examination provides information regarding the presence and location of the intimal tear(s) and the extent of the dissection flap, presence and quantification of the severity of AR due to dissection involving the aortic valve, detection of cardiac tamponade, and assessment of regional wall motion abnormalities indicating myocardial ischemia or infarction due to coronary dissection [
         <a href="#rid7">
          7,24
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Aortic cannulation
         </strong>
         –
         <strong>
         </strong>
         TEE can be used to guide placement of the aortic and other cannulae for CPB. (See
         <a class="medical medical_review" href="/z/d/html/88951.html" rel="external">
          "Overview of open surgical repair of the thoracic aorta", section on 'Ascending aorta'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For example, in a patient with aortic dissection, aortic cannulation may be performed using a Seldinger technique with a guidewire. TEE guidance can be used to identify the true and false lumens of the aorta and verify guidewire placement and cannula positioning within the true lumen  (
         <a class="graphic graphic_diagnosticimage graphicRef108395" href="/z/d/graphic/108395.html" rel="external">
          image 6
         </a>
         ). Although there are no definitive TEE criteria to distinguish the true from the false lumen in aortic dissection, typical features of the true lumen include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Smaller than the false lumen
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Continuity with the aortic valve
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Expansion during systole
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Rounded borders
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Blood flow through intimal fenestrations, with direction of flow from the true lumen into the false lumen
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Typical features of the false lumen include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Larger than the true lumen
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A crescent shape
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A sharp edge where the intimal flap joins the adventitia
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Presence of spontaneous echocardiographic contrast or thrombus due to a low flow state
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If CTA images of the aorta are available for viewing in the operating room, comparison of these with the intraoperative TEE images is useful to confirm correct identification of the true and false lumens after aortic dissection [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          During CPB
         </strong>
         – Upon initiation of CPB, intraoperative TEE is used to verify blood flow in the true lumen of the dissected aorta. TEE is also used to monitor for AR that will lead to LV distention before aortic crossclamping if ventricular fibrillation or asystole occur and ventricular ejection ceases. LV distention may also occur after application of the cross-clamp if the LV fills due during administration of antegrade cardioplegia to an incompetent aortic valve [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/130764.html" rel="external">
          "Management of special populations during cardiac surgery with cardiopulmonary bypass", section on 'Aortic regurgitation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         TEE monitoring is subsequently necessary to detect LV distention after the aortic crossclamp is removed (during the rewarming phase of CPB), which may occur if LV contraction is absent (ie, asystole) or infrequent (ie, bradycardia).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Weaning from CPB
         </strong>
         – Shortly before weaning from CPB, TEE is used to guide removal of intracardiac air from the left-sided cardiac chambers (ie, left atrium and LV) and aorta. (See
         <a class="medical medical_review" href="/z/d/html/115472.html" rel="external">
          "Intraoperative problems after cardiopulmonary bypass", section on 'Arterial air embolization'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If a valve-sparing procedure was performed (eg, aortic valve repair or resuspension), TEE can characterize aortic valve and aortic root structure and detect or quantify severity of residual AR [
         <a href="#rid1">
          1
         </a>
         ]. In some cases, it may be necessary to reinstitute CPB to perform additional aortic repair or to replace the aortic valve. Furthermore, aortic root reconstruction involves reimplantation of the coronary arteries into the prosthetic root graft. TEE can evaluate both LV and right ventricular (RV) function to verify that coronary blood flow has been properly restored. (See
         <a class="medical medical_review" href="/z/d/html/88951.html" rel="external">
          "Overview of open surgical repair of the thoracic aorta", section on 'Involvement of the aortic root'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postbypass period
         </strong>
         – In the postbypass period, TEE is used to note the presence or absence of residual dissection and blood flow patterns in the true and false lumens of the descending thoracic aorta, as well as detect iatrogenic new aortic dissection. TEE can also detect hypovolemia or blood in the pericardial or pleural cavities that may indicate ongoing surgical bleeding or coagulopathy. Furthermore, global LV and RV function may be impaired or recover slowly due to the effects of a long duration of CPB, as well as ischemia and reperfusion injury following the period of circulatory arrest. Frequent reassessment of LV and RV function with TEE facilitates management of inotropic and vasopressor support, as well as fluid administration to achieve optimal LV filling. (See
         <a class="medical medical_review" href="/z/d/html/126473.html" rel="external">
          "Anesthesia for cardiac surgery: General principles", section on 'Postbypass transesophageal echocardiography'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1506780671">
         <span class="h2">
          Brain monitors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intraoperative neuromonitoring is often used as an aid in managing hypothermia and monitoring for cerebral hypoperfusion [
         <a href="#rid2">
          2,7,18
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H584587810">
         <span class="h3">
          Electroencephalography
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Endpoint for cerebral effects of cooling
         </strong>
         –
         <strong>
         </strong>
         Deliberate hypothermia causes incremental changes in the electroencephalography (EEG) that correlate with the reduction of cerebral metabolic rate associated with hypothermia  (
         <a class="graphic graphic_figure graphicRef108373" href="/z/d/graphic/108373.html" rel="external">
          figure 2
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/91216.html" rel="external">
          "Neuromonitoring in surgery and anesthesia", section on 'Temperature'
         </a>
         ). Electrocortical silence on the EEG ensures hypothermia-induced maximum suppression of cerebral metabolic activity before CPB pump flow is discontinued to initiate circulatory arrest [
         <a href="#rid25">
          25-27
         </a>
         ]. EEG activity and electrocortical silence are better predictors of cerebral hypothermia than monitored temperature sites alone because brain and neuronal temperatures cannot be measured directly  (
         <a class="graphic graphic_figure graphicRef108490" href="/z/d/graphic/108490.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid25">
          25-28
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, the EEG is also affected by anesthetic agents. Volatile inhalation agents cause a dose-dependent decrease in EEG amplitude and frequency, and high doses of some intravenous (IV) anesthetic agents (eg,
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         ) cause burst suppression or electrocortical silence that cannot be distinguished from the effects of hypothermia. For this reason, if EEG guidance of deliberate hypothermia is being used, anesthetic agents should be discontinued as the EEG begins to slow or at the onset of burst suppression to avoid interference with the detection of hypothermia-induced electrocortical silence. If use of propofol or a barbiturate is planned as an adjunct for cerebral protection, administration is delayed until after the EEG endpoint or the target temperature for DHCA has been reached. (See
         <a class="local">
          'Considerations for anesthetic management'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/91216.html" rel="external">
          "Neuromonitoring in surgery and anesthesia", section on 'Anesthetic effects on neuromonitoring'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Processed EEG monitors such as the bispectral index (BIS) may be more readily available for emergency surgery (eg, acute ascending aortic dissection) than full neuromonitoring that includes multi-channel raw unprocessed EEG monitoring [
         <a href="#rid7">
          7
         </a>
         ]. The single raw EEG channel of a BIS or similar monitor can be continuously monitored. Although the digital BIS value appears to decrease reliably in response to progressive hypothermia, it is less sensitive than raw EEG for detecting electrocortical silence, only monitors the frontal cortex, and is more vulnerable to artifacts caused by anesthetic agents and neuromuscular blocking agents than the raw unprocessed EEG [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Monitoring for cerebral hypoperfusion
         </strong>
         –
         <strong>
         </strong>
         EEG monitoring may detect cerebral hypoperfusion manifesting as a decrease in EEG amplitude and frequency. Sudden decreases in amplitude and frequency or onset of seizure activity indicate an acute decrease in cerebral perfusion, particularly if also evident on a cerebral oximetry monitor (see
         <a class="local">
          'Cerebral oximetry'
         </a>
         below). Such abrupt changes should be promptly communicated to the surgeon and perfusionist since they may influence decisions regarding further intraoperative management [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Monitoring for awareness
         </strong>
         –
         <strong>
         </strong>
         Inadequate anesthetic depth resulting in awareness is possible during CPB, particularly during the rewarming phase after DHCA [
         <a href="#rid29">
          29,31
         </a>
         ]. To avoid inadequate anesthetic depth, administration of a volatile inhalation or IV anesthetic agents is resumed as soon as EEG activity has reappeared during the rewarming phase. (See
         <a class="local">
          'Considerations for anesthetic management'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/400.html" rel="external">
          "Accidental awareness during general anesthesia", section on 'Brain monitoring'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H742762996">
         <span class="h3">
          Cerebral oximetry
         </span>
         <span class="headingEndMark">
          —
         </span>
         Near-infrared spectroscopy (NIRS) cerebral oximetry is used in many centers to continuously monitor cerebral regional oxygen saturation (rSO
         <sub>
          2
         </sub>
         ) in the frontal cortex in patients undergoing major thoracic aortic operations with CPB and DHCA [
         <a href="#rid7">
          7,32-36
         </a>
         ]. NIRS is not affected by anesthetic agents or nonpulsatile perfusion during CPB.
        </p>
        <p>
         Typically, rSO
         <sub>
          2
         </sub>
         values increase as deliberate hypothermia is induced, then gradually decrease during either DHCA alone or DHCA with retrograde cerebral perfusion (RCP) once CPB pump flow has been discontinued for circulatory arrest [
         <a href="#rid37">
          37-47
         </a>
         ]. During DHCA with SACP, rSO
         <sub>
          2
         </sub>
         values increase or remain at baseline [
         <a href="#rid41">
          41,44,45
         </a>
         ]. Recovery of rSO
         <sub>
          2
         </sub>
         values toward baseline values occurs during reperfusion.
        </p>
        <p>
         A sudden unilateral decrease in rSO
         <sub>
          2
         </sub>
         during any stage of the procedure indicates a regional decrease in cerebral perfusion and should be promptly communicated to the surgeon and perfusionist since this may influence decisions regarding further intraoperative management [
         <a href="#rid7">
          7,36
         </a>
         ]. Bilateral sudden decreases in EEG amplitude and frequency indicates likely cerebral ischemia due to malperfusion [
         <a href="#rid7">
          7
         </a>
         ]. Examples include [
         <a href="#rid38">
          38,42,48-50
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         During onset of CPB, unilateral or bilateral decreases in rSO
         <sub>
          2
         </sub>
         may indicate malperfusion. Bypass is discontinued to evaluate and potentially revise cannulation sites used for CPB.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         During temporary clamping of the common carotid or innominate artery  (
         <a class="graphic graphic_diagnosticimage graphicRef108374" href="/z/d/graphic/108374.html" rel="external">
          image 7
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         An ipsilateral decrease in rSO
         <sub>
          2
         </sub>
         indicates decreased cerebral blood flow in the affected cerebral hemisphere, although this may not necessarily indicate cerebral ischemia or hypoperfusion since it does not provide a measure of neuronal function. Concomitant EEG and NIRS monitoring can determine if unilateral decreases in rSO
         <sub>
          2
         </sub>
         correlate with EEG evidence of cerebral ischemia or hypoperfusion.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A contralateral decrease in rSO
         <sub>
          2
         </sub>
         may occur due to vascular steal via a patent circle of Willis through the contralateral carotid artery that is open to the aortic arch. In this situation, clamping the contralateral carotid artery during SACP may improve cerebral perfusion to the contralateral hemisphere.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         During unilateral delivery of SACP:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         An acute decrease in rSO
         <sub>
          2
         </sub>
         on the ipsilateral side may indicate malpositioning of the SACP cannula.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A severe contralateral decrease in rSO
         <sub>
          2
         </sub>
         as unilateral SACP is initiated may influence the surgeon to additionally cannulate the contralateral carotid artery so that bilateral SACP is provided [
         <a href="#rid7">
          7,33,38-45
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Either unilateral (or bilateral) cerebral ischemia may also occur due to extension of aortic dissection or thrombosis of an arterial graft.
        </p>
        <p>
        </p>
        <p>
         Similar to other cardiac procedures, bilateral decreases in rSO
         <sub>
          2
         </sub>
         indicating global cerebral hypoperfusion may be observed during routine CPB. This may be due to hypoxemia, hypocarbia, anemia, venous hypertension, or inadequate anesthetic depth [
         <a href="#rid7">
          7,36
         </a>
         ]. Management of decreased rSO
         <sub>
          2
         </sub>
         during routine CPB is described separately  (
         <a class="graphic graphic_algorithm graphicRef108434" href="/z/d/graphic/108434.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">
          "Management of cardiopulmonary bypass", section on 'Neuromonitoring modalities'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3742267840">
         <span class="h2">
          Temperature monitors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Temperature is continuously monitored during initiation of CPB, cooling, the period of DHCA, rewarming, and throughout the postbypass period. Multiple temperature monitoring sites are used (eg, nasopharyngeal, blood [via the thermistor in the PAC], bladder [via a thermistor in the urinary catheter], tympanic membrane [via a thermistor in the ear canal]). Blood temperature is also monitored in the extracorporeal bypass circuit in both the arterial outlet blood temperature perfusing the patient and the venous blood inlet temperature re-entering the CPB circuit. (See
         <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">
          "Management of cardiopulmonary bypass", section on 'Temperature'
         </a>
         .)
        </p>
        <p>
         For temperature measurements using a nasopharyngeal probe, it is important to position the tip of the probe within the nasopharynx and not the esophagus. Esophageal temperatures are affected by ice or cardioplegic solution in the pericardial sac and may not accurately reflect brain temperature.
        </p>
        <p class="headingAnchor" id="H2134911250">
         <span class="h2">
          Laboratory testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intraoperative point-of-care testing includes arterial blood gas (ABG) measurements with pH and base deficit, hemoglobin, electrolytes, calcium, glucose, lactate, and activated whole blood clotting time (ACT).
        </p>
        <p>
         Results obtained from standard laboratory tests of hemostasis (eg, prothrombin time [PT], activated thromboplastin time [aPTT], and platelet count), as well as point-of-care viscoelastic tests of hemostasis (eg, thromboelastography [TEG] or rotational thromboelastometry [ROTEM]) if available, are used to guide administration of blood products in a bleeding patient [
         <a href="#rid51">
          51
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1368.html" rel="external">
          "Clinical use of coagulation tests"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/112610.html" rel="external">
          "Intraoperative transfusion and administration of clotting factors", section on 'Point-of-care tests'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H601144843">
         <span class="h1">
          THE PREBYPASS PERIOD
         </span>
        </p>
        <p class="headingAnchor" id="H2306424069">
         <span class="h2">
          Anesthetic management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Typical anesthetic management during the prebypass period for cardiac surgical procedures requiring cardiopulmonary bypass (CPB) is addressed in a separate topic. (See
         <a class="medical medical_review" href="/z/d/html/126473.html" rel="external">
          "Anesthesia for cardiac surgery: General principles"
         </a>
         .)
        </p>
        <p>
         Additional considerations for patients undergoing aortic surgery with deep hypothermia and elective circulatory arrest (DHCA) may include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Use of acute normovolemic hemodilution
         </strong>
         –
         <strong>
         </strong>
         Since blood loss is typically higher in complex procedures requiring a prolonged duration of CPB with a period of DHCA, acute normovolemic hemodilution
         <strong>
         </strong>
         may be used to reduce the need for intraoperative transfusion of red blood cells (RBCs) and other blood products in the postbypass period [
         <a href="#rid52">
          52
         </a>
         ]. (See
         <a class="local">
          'Control of coagulopathy to achieve hemostasis'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/7936.html" rel="external">
          "Surgical blood conservation: Acute normovolemic hemodilution"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Modifications in anesthetic agent selection and dosing
         </strong>
         –
         <strong>
         </strong>
         If electroencephalography (EEG) monitoring is being performed in anticipation of a period of DHCA, the dose of a volatile inhalation anesthetic is maintained at a fixed end-tidal concentration before cooling and discontinued at the onset of EEG burst suppression to minimize confounding anesthetic-induced EEG changes. Also, bolus doses of intravenous (IV) anesthetic agents are avoided if possible since these may produce acute transient changes in the EEG independent of temperature-induced changes. (See
         <a class="local">
          'Electroencephalography'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hemodynamic management
         </strong>
         –
         <strong>
         </strong>
         Most patients undergoing repair of the ascending aorta or arch have generalized cerebrovascular and ischemic heart disease. Avoidance and/or treatment of myocardial ischemia is similar to the approach for patients undergoing coronary artery bypass grafting (CABG) surgery. (See
         <a class="medical medical_review" href="/z/d/html/90607.html" rel="external">
          "Anesthesia for coronary artery bypass grafting surgery", section on 'Avoidance and treatment of ischemia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For patients with acute aortic syndromes (eg, aortic dissection), key hemodynamic considerations in the prebypass period also include fastidious control of systolic blood pressure (BP) and heart rate (HR) to minimize the likelihood of aortic rupture, progression of aortic dissection, or worsening aortic regurgitation (AR) and heart failure [
         <a href="#rid1">
          1
         </a>
         ]. Beta blockers (eg,
         <a class="drug drug_general" data-topicid="9420" href="/z/d/drug information/9420.html" rel="external">
          esmolol
         </a>
         ) are administered in small incremental doses to achieve a HR of 60 to 80 beats per minute and systolic BP &lt;120 mmHg. However, in patients with cardiogenic shock due to acute AR or cardiac tamponade, beta blockers are avoided. Details are discussed in a separate topic. (See
         <a class="medical medical_review" href="/z/d/html/8178.html" rel="external">
          "Overview of acute aortic dissection and other acute aortic syndromes", section on 'Anti-impulse therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Use of transesophageal echocardiography
         </strong>
         – Transesophageal echocardiography (TEE) is used to detect treatable causes of cardiogenic shock including cardiac tamponade, acute AR, hypotension due to hypovolemia, low systemic vascular resistance (SVR), or severe ventricular dysfunction. (See
         <a class="local">
          'Transesophageal echocardiography'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2088800182">
         <span class="h2">
          Preparations for cardiopulmonary bypass
         </span>
         <span class="headingEndMark">
          —
         </span>
         Standard preparations for initiation of CPB, including anticoagulation and antifibrinolytic administration, are discussed in separate topics  (
         <a class="graphic graphic_table graphicRef108173" href="/z/d/graphic/108173.html" rel="external">
          table 4
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/94297.html" rel="external">
          "Blood management and anticoagulation for cardiopulmonary bypass"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/115759.html" rel="external">
          "Initiation of cardiopulmonary bypass"
         </a>
         .)
        </p>
        <p>
         Additional considerations for patients undergoing procedures on the ascending aorta or aortic arch include selection of the site for arterial cannulation for CPB. This is most commonly an axillary artery site, but may be the aorta, or the innominate or femoral artery [
         <a href="#rid8">
          8
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/88951.html" rel="external">
          "Overview of open surgical repair of the thoracic aorta", section on 'Ascending aorta'
         </a>
         .)
        </p>
        <p>
         In patients with aortic dissection, TEE can be used to confirm wire placement in the true lumen of the vessel during arterial cannulation of the selected arterial site  (
         <a class="graphic graphic_diagnosticimage graphicRef108395" href="/z/d/graphic/108395.html" rel="external">
          image 6
         </a>
         ). (See
         <a class="local">
          'Transesophageal echocardiography'
         </a>
         above.)
        </p>
        <p>
         If retrograde cerebral perfusion (RCP) is planned as an adjunct to DHCA, rather than using a single right atrial cannula for venous drainage, separate cannulae are inserted into both the superior vena cava (SVC) and inferior vena cava (IVC) in order to separately perfuse the SVC  (
         <a class="graphic graphic_figure graphicRef108400" href="/z/d/graphic/108400.html" rel="external">
          figure 4
         </a>
         and
         <a class="graphic graphic_figure graphicRef107672" href="/z/d/graphic/107672.html" rel="external">
          figure 5
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/115759.html" rel="external">
          "Initiation of cardiopulmonary bypass", section on 'Venous cannulation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2250924233">
         <span class="h1">
          CARDIOPULMONARY BYPASS WITH DHCA
         </span>
         <span class="headingEndMark">
          —
         </span>
         Management of routine aspects of cardiopulmonary bypass (CPB) is addressed separately. (See
         <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">
          "Management of cardiopulmonary bypass"
         </a>
         .)
        </p>
        <p>
         Additional considerations for patients undergoing deeper levels of hypothermia are addressed below.
        </p>
        <p class="headingAnchor" id="H2934685196">
         <span class="h2">
          Deep hypothermia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many procedures involving the ascending aorta or aortic arch require temporary interruption of cerebral and systemic blood flow. During this period of elective circulatory arrest, the brain, spinal cord, and vital organs (kidneys, liver, and gastrointestinal tract) are protected by inducing deliberate hypothermia [
         <a href="#rid2">
          2
         </a>
         ]. Although the optimal temperature and safe duration for deep hypothermic circulatory arrest (DHCA) are unknown, experimental and clinical data support the effectiveness of DHCA lasting approximately 20 minutes, and up to 60 minutes in some cases  (
         <a class="graphic graphic_figure graphicRef108397" href="/z/d/graphic/108397.html" rel="external">
          figure 6
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H3719458190">
         <span class="h3">
          Cooling strategies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Active systemic cooling is accomplished after CPB has been established using the heat exchanger in the CPB circuit. All external patient warming devices are discontinued. The rate of cooling can be increased after application of the aortic cross clamp at the calculated full pump flow rate approximating normal cardiac index (typically 2.2 to 2.4 L/minute/m
         <sup>
          2
         </sup>
         in normothermic patients). After reaching the target temperature and/or confirming electrocortical silence on the electroencephalogram (EEG)  (
         <a class="graphic graphic_figure graphicRef108373" href="/z/d/graphic/108373.html" rel="external">
          figure 2
         </a>
         and
         <a class="graphic graphic_figure graphicRef108490" href="/z/d/graphic/108490.html" rel="external">
          figure 3
         </a>
         ) (see
         <a class="local">
          'Electroencephalography'
         </a>
         above), exsanguination into the CPB circuit and discontinuation of CPB pump flow establishes elective circulatory arrest [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1609930790">
         <span class="h3">
          Target temperature during DHCA
         </span>
         <span class="headingEndMark">
          —
         </span>
         The average nasopharyngeal temperature for electrocortical silence is 18°C; however, 50 percent of patients do not exhibit electrocortical silence at 18°C [
         <a href="#rid25">
          25,27
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Selection of a target temperature
         </strong>
         – The selected target temperature before initiating circulatory arrest for part of a specific surgical procedure varies and depends on the following considerations:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If EEG monitoring is available, it is used to ensure an endpoint of electrocortical silence indicating that hypothermia-induced maximum suppression of cerebral metabolic rate has been achieved before discontinuing CPB pump flow to initiate circulatory arrest  (
         <a class="graphic graphic_figure graphicRef108373" href="/z/d/graphic/108373.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid25">
          25-27
         </a>
         ]. Despite monitoring temperature at multiple sites, there is no direct way to measure actual brain temperature during CPB and DHCA. Thus, the presence of burst suppression or electrocortical silence on the EEG can be used as a neurophysiologic surrogate to monitor for adequacy of brain hypothermia  (
         <a class="graphic graphic_figure graphicRef108490" href="/z/d/graphic/108490.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid25">
          25-28
         </a>
         ]. (See
         <a class="local">
          'Electroencephalography'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If EEG monitoring is not available, nasopharyngeal and oxygenator arterial outlet temperature sites are used as the primary surrogate for brain temperature during cooling. Although a temperature of approximately 12.5°C would ensure that electrocortical silence has been achieved in &gt;99 percent of patients, a temperature of 16 to 18°C produces EEG electrocortical silence in most patients [
         <a href="#rid12">
          12,26,27
         </a>
         ]. A warmer temperature target in the range of 28°C may be selected if selective cerebral perfusion is provided during circulatory arrest, particularly if cold selective antegrade cerebral perfusion (SACP) is selected [
         <a href="#rid10">
          10,11
         </a>
         ]. (See
         <a class="local">
          'Selective cerebral perfusion during DHCA'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If the duration of DHCA is anticipated to be longer than 30 to 40 minutes, a target temperature closer to 12.5°C may be justified [
         <a href="#rid25">
          25-28
         </a>
         ]. If the anticipated duration of DHCA is brief (&lt;20 minutes), moderately deep hypothermia with a target temperature in the range of 20 to 28°C may be acceptable for brain protection. Mild hypothermia in the range of 28 to 34 °C is believed to provide &lt;10 minutes of safe circulatory arrest [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Other factors that influence target cooling temperatures include surgeon preference, institutional practice patterns, and established perfusion protocols.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Circuit temperature monitoring
         </strong>
         –
         <strong>
         </strong>
         Thermistors in the CPB circuit continuously monitor blood temperature. These thermistors are located at the arterial outlet of the oxygenator just before entry into the patient, as well as at the entry into the venous reservoir to sample venous blood re-entering the CPB circuit. The temperature gradient between the venous inflow from the patient and arterial outlet on the oxygenator for outflow to the patient is maintained at &lt;10°C. (See
         <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">
          "Management of cardiopulmonary bypass", section on 'Temperature'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The oxygenator arterial outlet temperature is used as the primary surrogate for the cerebral temperature target during cooling and maintenance of hypothermia [
         <a href="#rid53">
          53,54
         </a>
         ]. A nasopharyngeal or tympanic membrane temperature probe provides an additional estimate. (See
         <a class="local">
          'Electroencephalography'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Topical cooling
         </strong>
         –
         <strong>
         </strong>
         In some institutions, the patient's head is packed in ice bags to augment or maintain cerebral cooling. However, there is limited evidence to support the effectiveness of currently available techniques and devices, and topical cooling is not a substitute for systemic hypothermia delivered via CPB [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3064967514">
         <span class="h3">
          Duration of DHCA
         </span>
         <span class="headingEndMark">
          —
         </span>
         After target temperature is achieved, a duration of DHCA of 30 to 45 minutes is generally considered to be safe [
         <a href="#rid8">
          8
         </a>
         ]. Under normothermic conditions, irreversible ischemic neuronal injury is detected within four to five minutes after cerebral blood flow is interrupted. However, cerebral metabolic rate of oxygen consumption (CMRO
         <sub>
          2
         </sub>
         ) decreases by a factor of 2.3 for every 10°C decrease in body temperature  (
         <a class="graphic graphic_figure graphicRef108397" href="/z/d/graphic/108397.html" rel="external">
          figure 6
         </a>
         ) [
         <a href="#rid56">
          56,57
         </a>
         ]. Thus, if the brain's tolerance to ischemia is correlated solely with its metabolic rate, a five-minute tolerance for circulatory arrest at 37°C would increase to 25 to 38 minutes at temperatures of 13 to 20°C [
         <a href="#rid57">
          57
         </a>
         ]. Also, it is likely that hypothermia has protective actions independent of its effect on cerebral metabolism. Experimental studies suggest that hypothermia attenuates the release of excitatory neurotransmitters and inflammatory mediators, maintains the integrity of the blood–brain barrier, and helps to prevent neuronal apoptosis in response to ischemic injury.
        </p>
        <p>
         Clinical evidence suggests that the incidence of postoperative neurologic complications such as stroke, transient neurologic deficit, neurocognitive dysfunction, and seizures correlates with duration of DHCA, and is significantly associated with DHCA duration &gt;45 minutes [
         <a href="#rid13">
          13,58-60
         </a>
         ]. Experimental evidence in rats also demonstrates functional and histologic deficits after 30 to 60 minutes of DHCA [
         <a href="#rid61">
          61
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H780543503">
         <span class="h3">
          Selective cerebral perfusion during DHCA
         </span>
         <span class="headingEndMark">
          —
         </span>
         DHCA is often combined with SACP or retrograde cerebral perfusion (RCP) [
         <a href="#rid2">
          2
         </a>
         ]. Experimental and clinical data support use of these techniques to supplement the cerebral protection provided by deep hypothermia. There are no randomized trials comparing these techniques. (See
         <a class="local">
          'Review of the surgical plan'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H2163811579">
         <span class="h4">
          Selective antegrade cerebral perfusion
         </span>
         <span class="headingEndMark">
          —
         </span>
         SACP is used by many surgeons to reduce the period of cerebral ischemia during DHCA [
         <a href="#rid7">
          7,62-64
         </a>
         ]. Oxygenated blood at temperatures as low as 10 to 12°C is delivered via the CPB circuit into a directly cannulated axillary or innominate artery; the open ends of the aortic arch branch vessels; through a vascular graft sewn onto the axillary or subclavian artery; or a combination of these techniques  (
         <a class="graphic graphic_figure graphicRef108399" href="/z/d/graphic/108399.html" rel="external">
          figure 7
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/88951.html" rel="external">
          "Overview of open surgical repair of the thoracic aorta", section on 'Ascending aorta'
         </a>
         .)
        </p>
        <p>
         During SACP, decreases in unilateral or bilateral cerebral oximetry regional oxygen saturation (rSO
         <sub>
          2
         </sub>
         ) values may indicate cerebral hypoperfusion [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="local">
          'Cerebral oximetry'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H1014656699">
         <span class="h4">
          Retrograde cerebral perfusion
         </span>
         <span class="headingEndMark">
          —
         </span>
         RCP is a technique that provides partial perfusion to the brain and potentially prolongs the safe duration of circulatory arrest during DHCA when antegrade cerebral perfusion is interrupted [
         <a href="#rid7">
          7
         </a>
         ]. The superior vena cava (SVC) cannula is ensnared between the right atrium and the azygous vein, and cold oxygenated blood is perfused retrograde at a rate of 150 to 250 mL/minute into the SVC cannula  (
         <a class="graphic graphic_figure graphicRef108400" href="/z/d/graphic/108400.html" rel="external">
          figure 4
         </a>
         ). During RCP, the patient is maintained in a 10-degree Trendelenburg position to decrease the risk of cerebral air embolism. Using the side-port of an introducer sheath in the internal jugular vein, the anesthesiologist continuously monitors SVC pressure and guides RCP flow rates to maintain a pressure &lt;25 mmHg to prevent cerebral edema. (See
         <a class="medical medical_review" href="/z/d/html/88951.html" rel="external">
          "Overview of open surgical repair of the thoracic aorta", section on 'Ascending aorta'
         </a>
         .)
        </p>
        <p>
         Compared with SACP, there a greater risk of air embolism with RCP if any air remains in the venous CPB circuit catheter before initiating RCP. Furthermore, during DHCA, the metabolic demands of the brain are not fulfilled by RCP  (
         <a class="graphic graphic_figure graphicRef108398" href="/z/d/graphic/108398.html" rel="external">
          figure 8
         </a>
         ) [
         <a href="#rid65">
          65
         </a>
         ]. Similar to DHCA without RCP, a gradual decline in rSO
         <sub>
          2
         </sub>
         is typically observed with cerebral oximetry monitoring [
         <a href="#rid37">
          37,44,46,47
         </a>
         ] (see
         <a class="local">
          'Brain monitors'
         </a>
         above). However, the RCP technique does provide some degree of cerebral blood flow and serves to maintain brain hypothermia during DHCA, as well as possibly decreasing the risk of antegrade arterial air embolism or particulate thromboembolism when normal antegrade cerebral perfusion is resumed [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1436399090">
         <span class="h2">
          Considerations for anesthetic management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Deep hypothermia during CPB requires additional strategies for anesthetic administration and for management of hyperglycemia, anticoagulation, hemodilution, and acid-base status [
         <a href="#rid2">
          2
         </a>
         ]. Furthermore, residual effects of deep hypothermia on coagulation and the cardiovascular system influence postbypass management  (
         <a class="graphic graphic_table graphicRef109339" href="/z/d/graphic/109339.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'The postbypass period'
         </a>
         below.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anesthetic requirements
         </strong>
         – Since it is not possible to deliver any medication during circulatory arrest, any anesthetics, neuromuscular blocking agents, antibiotics, or other drugs that might be necessary should be administered before initiation of DHCA. All intravenous (IV) drug infusions and delivery of volatile anesthetic agents should be discontinued during the period of DHCA.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Anesthetic requirements are reduced during deliberate deep hypothermia, and general anesthesia is not needed after the onset of EEG burst suppression and throughout the period of electrocortical silence. However, anesthetic administration should be resumed during rewarming to ensure an anesthetized state when nasopharyngeal temperature has reached approximately 30°C or when consistent EEG activity has returned (typically approximately 30 minutes after initiating rewarming) [
         <a href="#rid66">
          66
         </a>
         ]. (See
         <a class="local">
          'Electroencephalography'
         </a>
         above and
         <a class="local">
          'Rewarming strategies'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management of hyperglycemia
         </strong>
         – Nearly all patients develop hyperglycemia after DHCA. This requires control with IV insulin administered by infusion during the remainder of CPB and throughout the postbypass period. As recommended in published guidelines, blood glucose concentration should be maintained &lt;180 mg/dL (10 mmol/L). However, it is important to monitor blood glucose frequently to prevent unintentional hypoglycemia. Details are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">
          "Management of cardiopulmonary bypass", section on 'Glucose'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anticoagulation
         </strong>
         – The duration of anticoagulation is somewhat prolonged during hypothermia due to delayed metabolism and excretion of heparin. During rewarming, heparin concentrations decrease as heparin is metabolized. Activated whole blood clotting time (ACT) is checked at least every 30 minutes during CPB in operations that require deep hypothermia. If available, plasma heparin concentrations are monitored using a point-of care (POC) heparin-protamine titration assay, as discussed in other topics. (See
         <a class="medical medical_review" href="/z/d/html/94297.html" rel="external">
          "Blood management and anticoagulation for cardiopulmonary bypass", section on 'Heparin administration and monitoring'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">
          "Management of cardiopulmonary bypass", section on 'Maintenance of anticoagulation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         After weaning from CPB, optimal neutralization of systemic anticoagulation with protamine is based on stoichiometric measurements of currently circulating heparin levels, using a POC heparin-protamine titration assay, as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/140293.html" rel="external">
          "Protamine: Administration and management of adverse reactions during cardiovascular procedures", section on 'Protamine administration after cardiopulmonary bypass'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acid-base management
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Blood gas management
         </strong>
         – Similar to routine CPB without deep hypothermia in adult patients [
         <a href="#rid67">
          67,68
         </a>
         ], we use alpha-stat blood gas management during cooling for DHCA and during rewarming. Evidence suggests that alpha-stat management (ie, temperature-uncorrected blood gas measurements) preserves cerebral blood flow autoregulation, as well as decreases risk of cerebral thromboembolism, cerebral edema, reperfusion injury, and unintended cerebral hyperthermia during rewarming [
         <a href="#rid69">
          69,70
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">
          "Management of cardiopulmonary bypass", section on 'Oxygenation, ventilation, and arterial blood gases'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Metabolic acidosis
         </strong>
         – Lactic acidosis commonly occurs during reperfusion after DHCA and may be associated with hyperkalemia. Blood lactate concentrations increase gradually after the onset of reperfusion and peak at an average concentration of 7.8 mmol/L approximately six hours after DHCA, with return to normal over 18 to 20 hours [
         <a href="#rid71">
          71
         </a>
         ]. Associated metabolic acidosis at an average pH nadir of 7.27 is present in approximately 80 percent of patients after DHCA, with return to normal over 12 to 14 hours [
         <a href="#rid71">
          71
         </a>
         ]. Although mild hyperventilation is commonly used to attenuate the severity of metabolic acidosis, excessive hyperventilation may have undesirable effects on cerebral blood flow. Pre-emptive management to minimize other causes of metabolic acidosis such as the use of buffered crystalloid solutions to prevent hyperchloremic acidosis may be helpful to decrease the overall severity of metabolic acidosis during reperfusion. Small doses of
         <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">
          sodium bicarbonate
         </a>
         8.4 percent (50 mEq/50 mL) may be titrated to treat metabolic acidosis if base deficit is &lt;–7 mEq/L or pH is &lt;7.20. However, we avoid excessive administration of sodium bicarbonate to prevent postoperative hypernatremia [
         <a href="#rid72">
          72
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hemodilution and anemia
         </strong>
         – As with patients undergoing CPB without a period of DHCA, we treat hemoglobin values &lt;7.5 g/dL with hemoconcentration, and transfusion if necessary. Hyperviscosity with potentially adverse effects on microcirculatory flow at deep hypothermic temperatures is a risk if hemoglobin levels are high (eg, &gt;10 g/dL) [
         <a href="#rid73">
          73
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">
          "Management of cardiopulmonary bypass", section on 'Hemoglobin/hematocrit'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Control of blood pressure
         </strong>
         – Mean arterial pressure (MAP) is maintained at 50 to 70 mmHg during the period after elective circulatory arrest. It is often necessary to treat higher MAP values with pharmacologic agents  (
         <a class="graphic graphic_table graphicRef119750" href="/z/d/graphic/119750.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H747152788">
         <span class="h2">
          Pharmacologic agents for cerebral protection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although
         <strong>
         </strong>
         pharmacologic adjuncts are commonly administered for cerebral protection, efficacy remains unproven [
         <a href="#rid1">
          1,2,74
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Barbiturates of
         </strong>
         <strong>
          propofol
         </strong>
         <strong>
         </strong>
         –
         <strong>
         </strong>
         The most used agents are barbiturates or
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         to further suppress cerebral electrocortical activity and the CMRO
         <sub>
          2
         </sub>
         prior to initiation of DHCA. Furthermore, concerns regarding adverse effects include myocardial depression and, in the case of long-acting barbiturates, the likelihood of delayed emergence from anesthesia [
         <a href="#rid75">
          75,76
         </a>
         ]. Also, administration of barbiturates, propofol, or volatile anesthetic agents interferes with the interpretation of temperature-dependent changes in intraoperative neurophysiologic monitoring and may cause premature onset of electrocortical silence on the EEG unrelated to brain temperature, metabolic activity, or hypothermic cerebral protection. For this reason, administration of these agents is delayed until after the EEG endpoint or the target temperature for DHCA has been reached. (See
         <a class="local">
          'Target temperature during DHCA'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/91216.html" rel="external">
          "Neuromonitoring in surgery and anesthesia", section on 'Anesthetic effects on neuromonitoring'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If a barbiturate or
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         is used to further suppress cerebral metabolic activity beyond the effects of hypothermia, dosing should be guided by the goal of achieving electrocortical silence during DHCA rather than using a fixed dose. Since the short-acting barbiturate thiopental has become unavailable in most countries, these centers use either the long-acting barbiturate
         <a class="drug drug_general" data-topicid="9754" href="/z/d/drug information/9754.html" rel="external">
          pentobarbital
         </a>
         (eg, 100 mg), or substitute propofol (eg, 2.5 mg/kg) due to its minimal effects on cardiac function [
         <a href="#rid77">
          77,78
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mannitol
         </strong>
         <strong>
         </strong>
         – Another agent is
         <a class="drug drug_general" data-topicid="9587" href="/z/d/drug information/9587.html" rel="external">
          mannitol
         </a>
         , which is often a component of the CPB pump prime solution because of its diuretic effects and theoretical free radical scavenging properties. However, there is insufficient evidence supporting its use for cerebral (or renal) protection [
         <a href="#rid79">
          79
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other agents
         </strong>
         –
         <strong>
         </strong>
         Other agents used in some institutions include anti-inflammatory or anticonvulsant agents,
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         , magnesium, or a calcium channel blocker [
         <a href="#rid1">
          1,2,80
         </a>
         ]. Clinicians cite minimal risk as justification for administering such pharmacologic adjuncts as well as theoretical physiologic and biochemical rationales for possible cerebral protection based on small clinical and experimental investigations or institutional practices.
        </p>
        <p>
        </p>
        <p>
         Evidence does not support the use of glucocorticoids for cerebral protection (eg, administration of preoperative oral
         <a class="drug drug_general" data-topicid="9808" href="/z/d/drug information/9808.html" rel="external">
          prednisolone
         </a>
         or administration of
         <a class="drug drug_general" data-topicid="9639" href="/z/d/drug information/9639.html" rel="external">
          methylprednisolone
         </a>
         during anesthetic induction or as bolus in the CPB pump prime). Concerns regarding adverse effects including abnormal glucose metabolism and immune system modulation have been reported, particularly with use of a high-dose regimen [
         <a href="#rid78">
          78,81-83
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2645067278">
         <span class="h2">
          Rewarming strategies
         </span>
         <span class="headingEndMark">
          —
         </span>
         We agree with professional society recommendations for rewarming guidelines that avoid cerebral hyperthermia [
         <a href="#rid1">
          1,53
         </a>
         ]. It is important to avoid cerebral hyperthermia because of its deleterious effects on the brain with potential exacerbation of ischemia-reperfusion injury following a period of elective circulatory arrest [
         <a href="#rid1">
          1,53,84-86
         </a>
         ]. Also, hyperthermia may exacerbate neurologic injury due to cerebral thromboembolic events that may occur during open aortic or open cardiotomy surgery. Thromboembolism of air or particulate debris is most likely at the time that cerebral perfusion resumes or after removal of the aortic crossclamp when ventricular ejection resumes.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Rate and duration of rewarming
         </strong>
         –
         <strong>
         </strong>
         After completion of the portion of the surgical repair requiring circulatory arrest with deep hypothermia, CPB is reinstituted with initial reperfusion of the brain at the original cold target temperature for approximately 10 minutes before beginning the rewarming process. During rewarming, while the arterial blood outlet temperature is &lt;30°C, a temperature gradient no greater than 10°C is maintained between the thermistor located at the venous inflow to the oxygenator and the thermistor located at the arterial outlet before entry into the patient. Once the arterial outlet temperature has reached 30°C, this venous-to-arterial temperature gradient should be no greater than 4°C. In general, rewarming should be accomplished slowly, with a rewarming rate limited to ≤0.5°C/minute. The time required to achieve such gradual rewarming after deep hypothermia to ≤16°C may be ≥90 minutes. At all times, we ensure that the arterial blood outlet temperature is no higher than 36.5°C. (See
         <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">
          "Management of cardiopulmonary bypass", section on 'Temperature'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Temperature monitoring during rewarming
         </strong>
         –
         <strong>
         </strong>
         We also ensure that the temperature at all monitoring sites is ≤37°C. During rewarming, the oxygenator arterial outlet temperature is used as the primary surrogate for cerebral temperature, although nasopharyngeal and/or tympanic membrane temperatures are also continuously monitored [
         <a href="#rid53">
          53,54
         </a>
         ]. The temperature of the venous blood returning into the venous reservoir of the CPB circuit estimates systemic temperature, while the bladder temperature provides an estimate of "core" temperature (ie, the body temperature at thermal equilibrium in the periphery). Clinical data have demonstrated that each of the temperature monitoring sites within the body (see
         <a class="local">
          'Temperature monitors'
         </a>
         above) underestimates temperature monitored with a jugular venous catheter positioned with its tip in the jugular bulb, considered to be the optimal site for monitoring cerebral temperature [
         <a href="#rid54">
          54,87
         </a>
         ]. Since monitoring jugular bulb temperature is not usually feasible, the best alternative for avoiding cerebral hyperthermia is to ensure that temperature at all monitored sites remains ≤37°C, even if this prolongs the rewarming process. (See
         <a class="medical medical_review" href="/z/d/html/103812.html" rel="external">
          "Management of cardiopulmonary bypass", section on 'Temperature'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Discontinuation of CPB
         </strong>
         –
         <strong>
         </strong>
         Many institutions discontinue CPB when the bladder temperature has reached 34.5 to 35.5 °C, thereby permitting mild hypothermia in the early postbypass period to provide some ongoing degree of cerebral protection. However, these potential cerebral protective effects are balanced against potential deleterious effects of hypothermia on coagulation and bleeding risk (see
         <a class="local">
          'Control of coagulopathy to achieve hemostasis'
         </a>
         below). Hence, there are wide institutional variations in the temperature target for discontinuing rewarming and weaning from CPB.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H346374535">
         <span class="h1">
          THE POSTBYPASS PERIOD
         </span>
         <span class="headingEndMark">
          —
         </span>
         The process of weaning from cardiopulmonary bypass (CPB) is discussed in a separate topic. (See
         <a class="medical medical_review" href="/z/d/html/90614.html" rel="external">
          "Weaning from cardiopulmonary bypass"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2586800049">
         <span class="h2">
          Problems in the postbypass period
         </span>
         <span class="headingEndMark">
          —
         </span>
         Postbypass problems after weaning from CPB are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/115472.html" rel="external">
          "Intraoperative problems after cardiopulmonary bypass"
         </a>
         .)
        </p>
        <p>
         The following problems are particularly challenging after CPB with deep hypothermia and circulatory arrest (DHCA) to achieve surgical repair or replacement of the ascending aorta or aortic arch.
        </p>
        <p class="headingAnchor" id="H3171661183">
         <span class="h3">
          Control of coagulopathy to achieve hemostasis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Surgical bleeding is exacerbated by coagulopathy due to  (
         <a class="graphic graphic_table graphicRef109339" href="/z/d/graphic/109339.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid7">
          7,14,15
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The anti-hemostatic effects of deep hypothermia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ischemia and reperfusion injury due to elective circulatory arrest
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fibrinolysis and platelet activation due to prolonged duration of CPB
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Underlying aortic vascular pathology and nature and extent of the surgical repair
        </p>
        <p>
        </p>
        <p>
         Intermittent measurements (approximately every 30 minutes) of hemoglobin (Hgb) are obtained to guide packed red blood cell (RBC) transfusion and avoid excessive hemodilution from crystalloid or colloid administration. Hemodilution and transfusion have both been associated with the risk of acute kidney injury after thoracic aortic surgery [
         <a href="#rid88">
          88-90
         </a>
         ].
        </p>
        <p>
         Management of persistent bleeding, anemia, massive transfusion, thrombocytopenia, and coagulopathy after CPB is addressed separately. (See
         <a class="medical medical_review" href="/z/d/html/122792.html" rel="external">
          "Achieving hemostasis after cardiac surgery with cardiopulmonary bypass"
         </a>
         .)
        </p>
        <p>
         In addition to bleeding and transfusion, dynamic intravascular fluid shifts occur after major thoracic aortic operations because of vasodilation during reperfusion. Intravascular volume status is assessed and monitored using transesophageal echocardiography (TEE) examinations and pulmonary artery catheter (PAC) measurements (eg, cardiac output [CO], mixed venous oxygen saturation [SvO
         <sub>
          2
         </sub>
         ], pulmonary artery pressure [PAP], and central venous pressure [CVP]). (See
         <a class="medical medical_review" href="/z/d/html/126473.html" rel="external">
          "Anesthesia for cardiac surgery: General principles", section on 'Postbypass management of fluids and blood products'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/126473.html" rel="external">
          "Anesthesia for cardiac surgery: General principles", section on 'Postbypass transesophageal echocardiography'
         </a>
         .)
        </p>
        <p>
         In rare cases, sternal closure must be delayed because of persistent bleeding, hemodynamic compromise during sternal approximation that compresses the right atrium and right ventricle (RV) within the mediastinum, or other technical problems. (See
         <a class="medical medical_review" href="/z/d/html/115472.html" rel="external">
          "Intraoperative problems after cardiopulmonary bypass", section on 'Inability to close the sternum'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1857921173">
         <span class="h3">
          Control of blood pressure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Episodes of hypertension and hypotension are common after aortic surgery with DHCA and should be promptly treated.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Postbypass control of hypertension with intravenous (IV) boluses or infusion of antihypertensive agents is critical to decreasing the risk of bleeding from fresh aortic anastomotic sites  (
         <a class="graphic graphic_table graphicRef119750" href="/z/d/graphic/119750.html" rel="external">
          table 2
         </a>
         ). Vasoconstriction due to residual hypothermia may cause or contribute to hypertension. Continuous infusion of antihypertensive agents is often necessary.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Postbypass hypotension may occur due to vasodilation as rewarming and reperfusion continue, or as a consequence of low CO. Vasoconstrictor or inotropic agents may be necessary  (
         <a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">
          table 3
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2652543355">
         <span class="h2">
          Transport to the intensive care unit
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hemostasis and hemodynamic stability must be achieved prior to transport to the intensive care unit (ICU). (See
         <a class="medical medical_review" href="/z/d/html/126473.html" rel="external">
          "Anesthesia for cardiac surgery: General principles", section on 'Transport and handoff in the intensive care unit'
         </a>
         .)
        </p>
        <p>
         In the ICU, patients typically remain sedated and tracheally intubated with controlled mechanical ventilation until thorough rewarming and hemodynamic stability are achieved, metabolic acidosis, bleeding, and coagulopathy have been corrected, and neurologic and pulmonary function are adequate for extubation. Coagulopathy and persistent bleeding and/or cardiac tamponade may require mediastinal re-exploration [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2335715521">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/118172.html" rel="external">
          "Society guideline links: Management of cardiopulmonary bypass"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/118036.html" rel="external">
          "Society guideline links: Aortic and other peripheral aneurysms"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/118034.html" rel="external">
          "Society guideline links: Aortic dissection and other acute aortic syndromes"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H346374705">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preanesthetic assessment and planning
         </strong>
         –
         <strong>
         </strong>
         Routine aspects of the preanesthetic consultation for cardiac surgery are discussed separately. (See
         <a class="local">
          'Preanesthetic assessment and planning'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Coexisting pathology
         </strong>
         –
         <strong>
         </strong>
         The presence of aortic or carotid arterial atherosclerosis; chronic or acute aortic regurgitation (AR)  (
         <a class="graphic graphic_movie graphicRef54254" href="/z/d/graphic/54254.html" rel="external">
          movie 2
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef79069" href="/z/d/graphic/79069.html" rel="external">
          image 3
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef106988" href="/z/d/graphic/106988.html" rel="external">
          image 4
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef106998" href="/z/d/graphic/106998.html" rel="external">
          image 5
         </a>
         ); cerebral, coronary, or limb malperfusion; or a mediastinal mass effect will influence anesthetic and surgical management. (See
         <a class="local">
          'Coexisting pathology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Review of the surgical plan
         </strong>
         – Specialized monitoring is used if the surgeon plans a period of moderately deep hypothermia (in the range of 20 to 28 °C) or deep hypothermia (in the range of 16 to 20°C) with elective circulatory arrest (DHCA) or with selective antegrade cerebral perfusion (SACP) or retrograde cerebral perfusion (RCP). (See
         <a class="local">
          'Review of the surgical plan'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Considerations for acute aortic dissection
         </strong>
         –
         <strong>
         </strong>
         Emergency surgical repair is necessary for acute type A aortic dissection  (
         <a class="graphic graphic_movie graphicRef99346" href="/z/d/graphic/99346.html" rel="external">
          movie 1
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef108394" href="/z/d/graphic/108394.html" rel="external">
          image 2
         </a>
         and
         <a class="graphic graphic_figure graphicRef100115" href="/z/d/graphic/100115.html" rel="external">
          figure 1
         </a>
         ). Factors that increase risk and affect anesthetic and surgical management may include acute AR, cardiac tamponade, acute coronary syndrome, stroke, visceral ischemia, malperfusion of extremities, and coagulopathy that worsens after DHCA.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Monitoring
         </strong>
         – Usual monitoring for cardiac surgery with cardiopulmonary bypass (CPB) is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/126473.html" rel="external">
          "Anesthesia for cardiac surgery: General principles", section on 'Monitoring'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Considerations specific for aortic surgery with DHCA include:
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Cardiovascular monitors
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Intra-arterial catheter
         </strong>
         – Selection of the cannulation site is affected by aortic pathology and the likely accuracy of blood pressure (BP) measurements in each upper extremity. (See
         <a class="local">
          'Intra-arterial catheter'
         </a>
         above and
         <a class="local">
          'Pulmonary artery catheter'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Echocardiography
         </strong>
         – Transesophageal echocardiography (TEE) can confirm the extent of aortic pathology and diagnosis and quantify severity of AR  (
         <a class="graphic graphic_movie graphicRef54254" href="/z/d/graphic/54254.html" rel="external">
          movie 2
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef79069" href="/z/d/graphic/79069.html" rel="external">
          image 3
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef106988" href="/z/d/graphic/106988.html" rel="external">
          image 4
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef106998" href="/z/d/graphic/106998.html" rel="external">
          image 5
         </a>
         ). TEE is also used to guide placement of cannulae for CPB, detect ventricular distention during CPB, and guide removal of intracardiac air during weaning from CPB
         <em>
          .
         </em>
         In emergency surgery for type A aortic dissection, intraoperative TEE examination is used to diagnose the extent of the dissection  (
         <a class="graphic graphic_movie graphicRef99346" href="/z/d/graphic/99346.html" rel="external">
          movie 1
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef108394" href="/z/d/graphic/108394.html" rel="external">
          image 2
         </a>
         ). (See
         <a class="local">
          'Transesophageal echocardiography'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Brain monitors
         </strong>
         – Processed or raw electroencephalography (EEG) may be used to confirm electrocortical silence due to hypothermia before establishing elective circulatory arrest, to potentially detect cerebral hypoperfusion and assess anesthetic depth. Cerebral oximetry with near-infrared spectroscopy may be used to detect and treat unilateral or bilateral cerebral hypoperfusion  (
         <a class="graphic graphic_diagnosticimage graphicRef108374" href="/z/d/graphic/108374.html" rel="external">
          image 7
         </a>
         and
         <a class="graphic graphic_algorithm graphicRef108434" href="/z/d/graphic/108434.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="local">
          'Brain monitors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Temperature monitors
         </strong>
         –
         <strong>
         </strong>
         Temperature is monitored at multiple body and CPB circuit sites. (See
         <a class="local">
          'Temperature monitors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Laboratory testing
         </strong>
         – Laboratory values are measured before, during, and after CPB. These include arterial blood gases (ABG), pH and base deficit, hemoglobin (Hgb), electrolytes, calcium, glucose, lactate, activated whole blood clotting time (ACT), and standard and viscoelastic tests of hemostasis. (See
         <a class="local">
          'Laboratory testing'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prebypass management
         </strong>
         –
         <strong>
         </strong>
         Key prebypass considerations
         <strong>
         </strong>
         for patients with acute aortic syndromes include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Systolic BP and heart rate (HR) are carefully controlled to achieve a HR of 60 to 80 beats per minute and systolic BP &lt;120 mmHg. Details are discussed in a separate topic. (See
         <a class="medical medical_review" href="/z/d/html/8178.html" rel="external">
          "Overview of acute aortic dissection and other acute aortic syndromes", section on 'Anti-impulse therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         TEE is used to detect treatable causes of cardiogenic shock including cardiac tamponade, acute AR, or hypotension due to hypovolemia or severe ventricular dysfunction. (See
         <a class="local">
          'Transesophageal echocardiography'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Use of deep hypothermia
         </strong>
         –
         <strong>
         </strong>
         Deliberate hypothermia is induced using CPB to provide protection of the brain and vital organs  (
         <a class="graphic graphic_figure graphicRef108397" href="/z/d/graphic/108397.html" rel="external">
          figure 6
         </a>
         ). (See
         <a class="local">
          'Deep hypothermia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Cooling
         </strong>
         – The oxygenator arterial outlet temperature is used as the primary surrogate for brain temperature during cooling. The average nasopharyngeal temperature is 18°C when CPB pump flow is discontinued for a period of elective circulatory arrest with or without selective cerebral perfusion techniques. In some centers, a hypothermic temperature that produces electrocortical silence is targeted, rather than using temperature monitors alone  (
         <a class="graphic graphic_figure graphicRef108373" href="/z/d/graphic/108373.html" rel="external">
          figure 2
         </a>
         and
         <a class="graphic graphic_figure graphicRef108490" href="/z/d/graphic/108490.html" rel="external">
          figure 3
         </a>
         ). (See
         <a class="local">
          'Cooling strategies'
         </a>
         above and
         <a class="local">
          'Target temperature during DHCA'
         </a>
         above and
         <a class="local">
          'Electroencephalography'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Duration of DHCA
         </strong>
         –
         <strong>
         </strong>
         A duration of DHCA of 30 to 45 minutes is generally safe. (See
         <a class="local">
          'Duration of DHCA'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Use of selective cerebral perfusion
         </strong>
         –
         <strong>
         </strong>
         Cerebral protection during moderately deep or deep hypothermia is often supplemented with SACP  (
         <a class="graphic graphic_figure graphicRef108399" href="/z/d/graphic/108399.html" rel="external">
          figure 7
         </a>
         ), or RCP  (
         <a class="graphic graphic_figure graphicRef108400" href="/z/d/graphic/108400.html" rel="external">
          figure 4
         </a>
         ), as discussed in a separate topic. (See
         <a class="medical medical_review" href="/z/d/html/88951.html" rel="external">
          "Overview of open surgical repair of the thoracic aorta", section on 'Ascending aorta'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Rewarming strategies
         </strong>
         –
         <strong>
         </strong>
         After a period of DHCA, CPB is reinstituted with gradual rewarming at a rate of ≤0.5°C/minute, which may require ≥90 minutes after deep hypothermia ≤16°C. To avoid cerebral hyperthermia that may exacerbate neurologic injury due to ischemia-reperfusion injury, the arterial blood outlet and nasopharyngeal temperatures are not allowed to exceed 36.5°C. (See
         <a class="local">
          'Rewarming strategies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Considerations for anesthetic management
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Anesthetic requirements
         </strong>
         –
         <strong>
         </strong>
         These are reduced during deep hypothermia, and anesthesia is unnecessary during the period of electrocortical silence. However, anesthetic administration should be resumed during rewarming and when EEG activity has returned to ensure absence of awareness. (See
         <a class="local">
          'Considerations for anesthetic management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Physiologic changes
         </strong>
         – Strategies to manage hyperglycemia, anticoagulation, acid-base status, hemodilution and anemia are discussed above  (
         <a class="graphic graphic_table graphicRef109339" href="/z/d/graphic/109339.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Considerations for anesthetic management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postbypass period
         </strong>
         –
         <strong>
         </strong>
         Surgical bleeding is exacerbated by coagulopathy due to the anti-hemostatic effects of deep hypothermia, ischemia and reperfusion injury due to elective circulatory arrest, fibrinolysis and platelet activation due to prolonged duration of CPB, underlying aortic vascular pathology, and the nature and extent of the surgical repair. Episodes of both hypertension and hypotension are common and should be promptly treated. (See
         <a class="local">
          'Problems in the postbypass period'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010; 121:e266.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghia S, Savadjian A, Shin D, et al. Hypothermic Circulatory Arrest in Adult Aortic Arch Surgery: A Review of Hypothermic Circulatory Arrest and its Anesthetic Implications. J Cardiothorac Vasc Anesth 2023; 37:2634.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nishiwaki K, Komatsu T, Shimada Y, et al. Severe tracheal compression caused by false aneurysm arising from the ascending aorta: successful airway management using induced hypotension and bronchoscopy. Anesthesiology 1990; 73:1047.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MacGillivray RG. Tracheal compression caused by aneurysms of the aortic arch. Implications for the anaesthetist. Anaesthesia 1985; 40:270.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kutcher WL, Kaufman BS. Occlusion of the right pulmonary artery by an acute dissecting aortic aneurysm. Crit Care Med 1988; 16:564.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Downey RJ, Austin JH, Pepino P, et al. Right ventricular obstruction in aortic dissection: a mechanism of hemodynamic collapse. Ann Thorac Surg 1996; 61:988.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gregory SH, Yalamuri SM, Bishawi M, Swaminathan M. The Perioperative Management of Ascending Aortic Dissection. Anesth Analg 2018; 127:1302.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yan TD, Bannon PG, Bavaria J, et al. Consensus on hypothermia in aortic arch surgery. Ann Cardiothorac Surg 2013; 2:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pupovac SS, Hemli JM, Bavaria JE, et al. Moderate Versus Deep Hypothermia in Type A Acute Aortic Dissection Repair: Insights from the International Registry of Acute Aortic Dissection. Ann Thorac Surg 2021; 112:1893.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hu Z, Wang Z, Ren Z, et al. Similar cerebral protective effectiveness of antegrade and retrograde cerebral perfusion combined with deep hypothermia circulatory arrest in aortic arch surgery: a meta-analysis and systematic review of 5060 patients. J Thorac Cardiovasc Surg 2014; 148:544.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cook RC, Gao M, Macnab AJ, et al. Aortic arch reconstruction: safety of moderate hypothermia and antegrade cerebral perfusion during systemic circulatory arrest. J Card Surg 2006; 21:158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gega A, Rizzo JA, Johnson MH, et al. Straight deep hypothermic arrest: experience in 394 patients supports its effectiveness as a sole means of brain preservation. Ann Thorac Surg 2007; 84:759.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chau KH, Ziganshin BA, Elefteriades JA. Deep hypothermic circulatory arrest: real-life suspended animation. Prog Cardiovasc Dis 2013; 56:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolberg AS, Meng ZH, Monroe DM 3rd, Hoffman M. A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 2004; 56:1221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Warren OJ, Smith AJ, Alexiou C, et al. The inflammatory response to cardiopulmonary bypass: part 1--mechanisms of pathogenesis. J Cardiothorac Vasc Anesth 2009; 23:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Warren OJ, Watret AL, de Wit KL, et al. The inflammatory response to cardiopulmonary bypass: part 2--anti-inflammatory therapeutic strategies. J Cardiothorac Vasc Anesth 2009; 23:384.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gregory AJ, Appoo JJ, Acero-Martinez N, et al. Evolving Concepts in the Perioperative Management of Acute Stanford Type-A Aortic Dissection. J Anesth Periop Med 2018; 5:200.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaudino M, Benesch C, Bakaeen F, et al. Considerations for Reduction of Risk of Perioperative Stroke in Adult Patients Undergoing Cardiac and Thoracic Aortic Operations: A Scientific Statement From the American Heart Association. Circulation 2020; 142:e193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thurau J, Habazettl H, El Al Md AA, et al. Left Ventricular Systolic Dysfunction in Patients With Type-A Aortic Dissection Is Associated With 30-Day Mortality. J Cardiothorac Vasc Anesth 2019; 33:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ullery BW, Hobbs RD, Cheung AT. Reversible spinal cord ischemia as a complication of acute aortic intramural hematoma. Vascular 2015; 23:427.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zindovic I, Sjögren J, Bjursten H, et al. The Coagulopathy of Acute Type A Aortic Dissection: A Prospective, Observational Study. J Cardiothorac Vasc Anesth 2019; 33:2746.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           American Society of Anesthesiologists and Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology 2010; 112:1084.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MacKay EJ, Zhang B, Augoustides JG, et al. Association of Intraoperative Transesophageal Echocardiography and Clinical Outcomes After Open Cardiac Valve or Proximal Aortic Surgery. JAMA Netw Open 2022; 5:e2147820.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MacKnight BM, Maldonado Y, Augoustides JG, et al. Advances in Imaging for the Management of Acute Aortic Syndromes: Focus on Transesophageal Echocardiography and Type-A Aortic Dissection for the Perioperative Echocardiographer. J Cardiothorac Vasc Anesth 2016; 30:1129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stecker MM, Cheung AT, Pochettino A, et al. Deep hypothermic circulatory arrest: I. Effects of cooling on electroencephalogram and evoked potentials. Ann Thorac Surg 2001; 71:14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           James ML, Andersen ND, Swaminathan M, et al. Predictors of electrocerebral inactivity with deep hypothermia. J Thorac Cardiovasc Surg 2014; 147:1002.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Englum BR, Andersen ND, Husain AM, et al. Degree of hypothermia in aortic arch surgery - optimal temperature for cerebral and spinal protection: deep hypothermia remains the gold standard in the absence of randomized data. Ann Cardiothorac Surg 2013; 2:184.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coselli JS, Crawford ES, Beall AC Jr, et al. Determination of brain temperatures for safe circulatory arrest during cardiovascular operation. Ann Thorac Surg 1988; 45:638.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kertai MD, Whitlock EL, Avidan MS. Brain monitoring with electroencephalography and the electroencephalogram-derived bispectral index during cardiac surgery. Anesth Analg 2012; 114:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hemmerling TM, Olivier JF, Basile F, et al. Bispectral index as an indicator of cerebral hypoperfusion during off-pump coronary artery bypass grafting. Anesth Analg 2005; 100:354.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chandran Mahaldar DA, Gadhinglajkar S, Sreedhar R. Sevoflurane requirement to maintain bispectral index-guided steady-state level of anesthesia during the rewarming phase of cardiopulmonary bypass with moderate hypothermia. J Cardiothorac Vasc Anesth 2013; 27:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murkin JM, Adams SJ, Novick RJ, et al. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg 2007; 104:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zheng F, Sheinberg R, Yee MS, et al. Cerebral near-infrared spectroscopy monitoring and neurologic outcomes in adult cardiac surgery patients: a systematic review. Anesth Analg 2013; 116:663.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Subramanian B, Nyman C, Fritock M, et al. A Multicenter Pilot Study Assessing Regional Cerebral Oxygen Desaturation Frequency During Cardiopulmonary Bypass and Responsiveness to an Intervention Algorithm. Anesth Analg 2016; 122:1786.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steppan J, Hogue CW Jr. Cerebral and tissue oximetry. Best Pract Res Clin Anaesthesiol 2014; 28:429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thiele RH, Shaw AD, Bartels K, et al. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on the Role of Neuromonitoring in Perioperative Outcomes: Cerebral Near-Infrared Spectroscopy. Anesth Analg 2020; 131:1444.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fischer GW, Lin HM, Krol M, et al. Noninvasive cerebral oxygenation may predict outcome in patients undergoing aortic arch surgery. J Thorac Cardiovasc Surg 2011; 141:815.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rubio A, Hakami L, Münch F, et al. Noninvasive control of adequate cerebral oxygenation during low-flow antegrade selective cerebral perfusion on adults and infants in the aortic arch surgery. J Card Surg 2008; 23:474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Orihashi K, Sueda T, Okada K, Imai K. Near-infrared spectroscopy for monitoring cerebral ischemia during selective cerebral perfusion. Eur J Cardiothorac Surg 2004; 26:907.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olsson C, Thelin S. Regional cerebral saturation monitoring with near-infrared spectroscopy during selective antegrade cerebral perfusion: diagnostic performance and relationship to postoperative stroke. J Thorac Cardiovasc Surg 2006; 131:371.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aono M, Sata J, Nishino T. [Regional cerebral oxygen saturation as a monitor of cerebral oxygenation and perfusion during deep hypothermic circulatory arrest and selective cerebral perfusion]. Masui 1998; 47:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Orihashi K, Sueda T, Okada K, Imai K. Malposition of selective cerebral perfusion catheter is not a rare event. Eur J Cardiothorac Surg 2005; 27:644.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harrer M, Waldenberger FR, Weiss G, et al. Aortic arch surgery using bilateral antegrade selective cerebral perfusion in combination with near-infrared spectroscopy. Eur J Cardiothorac Surg 2010; 38:561.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Higami T, Kozawa S, Asada T, et al. Retrograde cerebral perfusion versus selective cerebral perfusion as evaluated by cerebral oxygen saturation during aortic arch reconstruction. Ann Thorac Surg 1999; 67:1091.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yamashita K, Kazui T, Terada H, et al. Cerebral oxygenation monitoring for total arch replacement using selective cerebral perfusion. Ann Thorac Surg 2001; 72:503.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blas ML, Lobato EB, Martin T. Noninvasive infrared spectroscopy as a monitor of retrograde cerebral perfusion during deep hypothermia. J Cardiothorac Vasc Anesth 1999; 13:244.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ogino H, Ueda Y, Sugita T, et al. Monitoring of regional cerebral oxygenation by near-infrared spectroscopy during continuous retrograde cerebral perfusion for aortic arch surgery. Eur J Cardiothorac Surg 1998; 14:415.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Janelle GM, Mnookin S, Gravenstein N, et al. Unilateral cerebral oxygen desaturation during emergent repair of a DeBakey type 1 aortic dissection: potential aversion of a major catastrophe. Anesthesiology 2002; 96:1263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Santo KC, Barrios A, Dandekar U, et al. Near-infrared spectroscopy: an important monitoring tool during hybrid aortic arch replacement. Anesth Analg 2008; 107:793.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Orihashi K, Sueda T, Okada K, Imai K. Detection and monitoring of complications associated with femoral or axillary arterial cannulation for surgical repair of aortic dissection. J Cardiothorac Vasc Anesth 2006; 20:20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rhee AJ, Kahn RA. Laboratory point-of-care monitoring in the operating room. Curr Opin Anaesthesiol 2010; 23:741.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geube M, Sale S, Bakdash S, et al. Prepump autologous blood collection is associated with reduced intraoperative transfusions in aortic surgery with circulatory arrest: A propensity score-matched analysis. J Thorac Cardiovasc Surg 2022; 164:1572.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Engelman R, Baker RA, Likosky DS, et al. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines for Cardiopulmonary Bypass--Temperature Management During Cardiopulmonary Bypass. Ann Thorac Surg 2015; 100:748.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nussmeier NA, Cheng W, Marino M, et al. Temperature during cardiopulmonary bypass: the discrepancies between monitored sites. Anesth Analg 2006; 103:1373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guvakov D, Bezinover D, Lomivorotov VV, et al. The "Ice Age" in Cardiac Surgery: Evolution of the "Siberian" Method of Brain Protection During Deep Hypothermic Perfusionless Circulatory Arrest. J Cardiothorac Vasc Anesth 2019; 33:3366.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           GORDON AS, MEYER BW, JONES JC. Open-heart surgery using deep hypothermia without an oxygenator. J Thorac Cardiovasc Surg 1960; 40:787.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCullough JN, Zhang N, Reich DL, et al. Cerebral metabolic suppression during hypothermic circulatory arrest in humans. Ann Thorac Surg 1999; 67:1895.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaynor JW, Nicolson SC, Jarvik GP, et al. Increasing duration of deep hypothermic circulatory arrest is associated with an increased incidence of postoperative electroencephalographic seizures. J Thorac Cardiovasc Surg 2005; 130:1278.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Okita Y, Minatoya K, Tagusari O, et al. Prospective comparative study of brain protection in total aortic arch replacement: deep hypothermic circulatory arrest with retrograde cerebral perfusion or selective antegrade cerebral perfusion. Ann Thorac Surg 2001; 72:72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fleck TM, Czerny M, Hutschala D, et al. The incidence of transient neurologic dysfunction after ascending aortic replacement with circulatory arrest. Ann Thorac Surg 2003; 76:1198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jungwirth B, Mackensen GB, Blobner M, et al. Neurologic outcome after cardiopulmonary bypass with deep hypothermic circulatory arrest in rats: description of a new model. J Thorac Cardiovasc Surg 2006; 131:805.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bachet J. What is the best method for brain protection in surgery of the aortic arch? Selective antegrade cerebral perfusion. Cardiol Clin 2010; 28:389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leontyev S, Davierwala PM, Semenov M, et al. Antegrade selective cerebral perfusion reduced in-hospital mortality and permanent focal neurological deficit in patients with elective aortic arch surgery†. Eur J Cardiothorac Surg 2019; 56:1001.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kazui T, Inoue N, Yamada O, Komatsu S. Selective cerebral perfusion during operation for aneurysms of the aortic arch: a reassessment. Ann Thorac Surg 1992; 53:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheung AT, Bavaria JE, Pochettino A, et al. Oxygen delivery during retrograde cerebral perfusion in humans. Anesth Analg 1999; 88:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stecker MM, Cheung AT, Pochettino A, et al. Deep hypothermic circulatory arrest: II. Changes in electroencephalogram and evoked potentials during rewarming. Ann Thorac Surg 2001; 71:22.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murphy GS, Hessel EA 2nd, Groom RC. Optimal perfusion during cardiopulmonary bypass: an evidence-based approach. Anesth Analg 2009; 108:1394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hogue CW Jr, Palin CA, Arrowsmith JE. Cardiopulmonary bypass management and neurologic outcomes: an evidence-based appraisal of current practices. Anesth Analg 2006; 103:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Groom RC, Froebe S, Martin J, et al. Update on pediatric perfusion practice in North America: 2005 survey. J Extra Corpor Technol 2005; 37:343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Connolly S, Arrowsmith JE, Klein AA. Deep hypothermic circulatory arrest. continuing education in anaesthesia, critical care &amp; pain 2010; 10:138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghadimi K, Gutsche JT, Setegne SL, et al. Severity and Duration of Metabolic Acidosis After Deep Hypothermic Circulatory Arrest for Thoracic Aortic Surgery. J Cardiothorac Vasc Anesth 2015; 29:1432.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghadimi K, Gutsche JT, Ramakrishna H, et al. Sodium bicarbonate use and the risk of hypernatremia in thoracic aortic surgical patients with metabolic acidosis following deep hypothermic circulatory arrest. Ann Card Anaesth 2016; 19:454.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang Y, Ji H. Comparison of Two Different Red Blood Cell Transfusion Thresholds on Short-Term Clinical Outcomes of Patients Undergoing Aortic Surgery With Deep Hypothermic Circulatory Arrest. J Cardiothorac Vasc Anesth 2016; 30:1163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slupe AM, Kirsch JR. Effects of anesthesia on cerebral blood flow, metabolism, and neuroprotection. J Cereb Blood Flow Metab 2018; 38:2192.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Hashimi S, Zaman M, Waterworth P, Bilal H. Does the use of thiopental provide added cerebral protection during deep hypothermic circulatory arrest? Interact Cardiovasc Thorac Surg 2013; 17:392.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stone JG, Young WL, Marans ZS, et al. Consequences of electroencephalographic-suppressive doses of propofol in conjunction with deep hypothermic circulatory arrest. Anesthesiology 1996; 85:497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Banks DA, Pretorius GV, Kerr KM, Manecke GR. Pulmonary endarterectomy: Part II. Operation, anesthetic management, and postoperative care. Semin Cardiothorac Vasc Anesth 2014; 18:331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ng O, Giménez-Milà M, Jenkins DP, Vuylsteke A. Perioperative Management of Pulmonary Endarterectomy-Perspective from the UK National Health Service. J Cardiothorac Vasc Anesth 2019; 33:3101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krüger T, Hoffmann I, Blettner M, et al. Intraoperative neuroprotective drugs without beneficial effects? Results of the German Registry for Acute Aortic Dissection Type A (GERAADA). Eur J Cardiothorac Surg 2013; 44:939.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dewhurst AT, Moore SJ, Liban JB. Pharmacological agents as cerebral protectants during deep hypothermic circulatory arrest in adult thoracic aortic surgery. A survey of current practice. Anaesthesia 2002; 57:1016.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kerr KM, Auger WR, Marsh JJ, et al. Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy. Chest 2012; 141:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Svyatets M, Tolani K, Zhang M, et al. Perioperative management of deep hypothermic circulatory arrest. J Cardiothorac Vasc Anesth 2010; 24:644.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dvirnik N, Belley-Cote EP, Hanif H, et al. Steroids in cardiac surgery: a systematic review and meta-analysis. Br J Anaesth 2018; 120:657.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grigore AM, Grocott HP, Mathew JP, et al. The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery. Anesth Analg 2002; 94:4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grocott HP, Mackensen GB, Grigore AM, et al. Postoperative hyperthermia is associated with cognitive dysfunction after coronary artery bypass graft surgery. Stroke 2002; 33:537.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bar-Yosef S, Mathew JP, Newman MF, et al. Prevention of cerebral hyperthermia during cardiac surgery by limiting on-bypass rewarming in combination with post-bypass body surface warming: a feasibility study. Anesth Analg 2004; 99:641.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akata T, Setoguchi H, Shirozu K, Yoshino J. Reliability of temperatures measured at standard monitoring sites as an index of brain temperature during deep hypothermic cardiopulmonary bypass conducted for thoracic aortic reconstruction. J Thorac Cardiovasc Surg 2007; 133:1559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim WH, Park MH, Kim HJ, et al. Potentially modifiable risk factors for acute kidney injury after surgery on the thoracic aorta: a propensity score matched case-control study. Medicine (Baltimore) 2015; 94:e273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parolari A, Pesce LL, Pacini D, et al. Risk factors for perioperative acute kidney injury after adult cardiac surgery: role of perioperative management. Ann Thorac Surg 2012; 93:584.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arnaoutakis GJ, Bihorac A, Martin TD, et al. RIFLE criteria for acute kidney injury in aortic arch surgery. J Thorac Cardiovasc Surg 2007; 134:1554.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 94292 Version 25.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20233780" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37723023" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Hypothermic Circulatory Arrest in Adult Aortic Arch Surgery: A Review of Hypothermic Circulatory Arrest and its Anesthetic Implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2240659" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Severe tracheal compression caused by false aneurysm arising from the ascending aorta: successful airway management using induced hypotension and bronchoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3993884" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Tracheal compression caused by aneurysms of the aortic arch. Implications for the anaesthetist.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3359795" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Occlusion of the right pulmonary artery by an acute dissecting aortic aneurysm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8619733" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Right ventricular obstruction in aortic dissection: a mechanism of hemodynamic collapse.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30211773" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : The Perioperative Management of Ascending Aortic Dissection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23977577" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Consensus on hypothermia in aortic arch surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33515541" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Moderate Versus Deep Hypothermia in Type A Acute Aortic Dissection Repair: Insights from the International Registry of Acute Aortic Dissection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24332107" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Similar cerebral protective effectiveness of antegrade and retrograde cerebral perfusion combined with deep hypothermia circulatory arrest in aortic arch surgery: a meta-analysis and systematic review of 5060 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16492276" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Aortic arch reconstruction: safety of moderate hypothermia and antegrade cerebral perfusion during systemic circulatory arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17720372" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Straight deep hypothermic arrest: experience in 394 patients supports its effectiveness as a sole means of brain preservation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23993241" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Deep hypothermic circulatory arrest: real-life suspended animation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15211129" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18930659" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The inflammatory response to cardiopulmonary bypass: part 1--mechanisms of pathogenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19054695" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : The inflammatory response to cardiopulmonary bypass: part 2--anti-inflammatory therapeutic strategies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Evolving Concepts in the Perioperative Management of Acute Stanford Type-A Aortic Dissection
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32842767" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Considerations for Reduction of Risk of Perioperative Stroke in Adult Patients Undergoing Cardiac and Thoracic Aortic Operations: A Scientific Statement From the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30177474" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Left Ventricular Systolic Dysfunction in Patients With Type-A Aortic Dissection Is Associated With 30-Day Mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25193357" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Reversible spinal cord ischemia as a complication of acute aortic intramural hematoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30876766" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : The Coagulopathy of Acute Type A Aortic Dissection: A Prospective, Observational Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20418689" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35138396" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Association of Intraoperative Transesophageal Echocardiography and Clinical Outcomes After Open Cardiac Valve or Proximal Aortic Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27179612" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Advances in Imaging for the Management of Acute Aortic Syndromes: Focus on Transesophageal Echocardiography and Type-A Aortic Dissection for the Perioperative Echocardiographer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11216734" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Deep hypothermic circulatory arrest: I. Effects of cooling on electroencephalogram and evoked potentials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23582829" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Predictors of electrocerebral inactivity with deep hypothermia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23977581" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Degree of hypothermia in aortic arch surgery - optimal temperature for cerebral and spinal protection: deep hypothermia remains the gold standard in the absence of randomized data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3377576" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Determination of brain temperatures for safe circulatory arrest during cardiovascular operation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22253267" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Brain monitoring with electroencephalography and the electroencephalogram-derived bispectral index during cardiac surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15673855" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Bispectral index as an indicator of cerebral hypoperfusion during off-pump coronary artery bypass grafting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22819589" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Sevoflurane requirement to maintain bispectral index-guided steady-state level of anesthesia during the rewarming phase of cardiopulmonary bypass with moderate hypothermia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17179242" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23267000" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Cerebral near-infrared spectroscopy monitoring and neurologic outcomes in adult cardiac surgery patients: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27028775" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : A Multicenter Pilot Study Assessing Regional Cerebral Oxygen Desaturation Frequency During Cardiopulmonary Bypass and Responsiveness to an Intervention Algorithm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25480772" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Cerebral and tissue oximetry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33079868" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on the Role of Neuromonitoring in Perioperative Outcomes: Cerebral Near-Infrared Spectroscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20579669" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Noninvasive cerebral oxygenation may predict outcome in patients undergoing aortic arch surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18928485" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Noninvasive control of adequate cerebral oxygenation during low-flow antegrade selective cerebral perfusion on adults and infants in the aortic arch surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15519181" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Near-infrared spectroscopy for monitoring cerebral ischemia during selective cerebral perfusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16434267" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Regional cerebral saturation monitoring with near-infrared spectroscopy during selective antegrade cerebral perfusion: diagnostic performance and relationship to postoperative stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9560547" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : [Regional cerebral oxygen saturation as a monitor of cerebral oxygenation and perfusion during deep hypothermic circulatory arrest and selective cerebral perfusion].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15784366" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Malposition of selective cerebral perfusion catheter is not a rare event.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20409728" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Aortic arch surgery using bilateral antegrade selective cerebral perfusion in combination with near-infrared spectroscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10320256" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Retrograde cerebral perfusion versus selective cerebral perfusion as evaluated by cerebral oxygen saturation during aortic arch reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11515889" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Cerebral oxygenation monitoring for total arch replacement using selective cerebral perfusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10230970" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Noninvasive infrared spectroscopy as a monitor of retrograde cerebral perfusion during deep hypothermia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9845148" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Monitoring of regional cerebral oxygenation by near-infrared spectroscopy during continuous retrograde cerebral perfusion for aortic arch surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11981170" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Unilateral cerebral oxygen desaturation during emergent repair of a DeBakey type 1 aortic dissection: potential aversion of a major catastrophe.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18713886" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Near-infrared spectroscopy: an important monitoring tool during hybrid aortic arch replacement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16458208" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Detection and monitoring of complications associated with femoral or axillary arterial cannulation for surgical repair of aortic dissection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20881483" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Laboratory point-of-care monitoring in the operating room.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33610366" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Prepump autologous blood collection is associated with reduced intraoperative transfusions in aortic surgery with circulatory arrest: A propensity score-matched analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26234862" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines for Cardiopulmonary Bypass--Temperature Management During Cardiopulmonary Bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17122206" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Temperature during cardiopulmonary bypass: the discrepancies between monitored sites.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31129071" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : The "Ice Age" in Cardiac Surgery: Evolution of the "Siberian" Method of Brain Protection During Deep Hypothermic Perfusionless Circulatory Arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13707141" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Open-heart surgery using deep hypothermia without an oxygenator.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10391334" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Cerebral metabolic suppression during hypothermic circulatory arrest in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16256779" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Increasing duration of deep hypothermic circulatory arrest is associated with an increased incidence of postoperative electroencephalographic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11465234" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Prospective comparative study of brain protection in total aortic arch replacement: deep hypothermic circulatory arrest with retrograde cerebral perfusion or selective antegrade cerebral perfusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14530011" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : The incidence of transient neurologic dysfunction after ascending aortic replacement with circulatory arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16580438" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Neurologic outcome after cardiopulmonary bypass with deep hypothermic circulatory arrest in rats: description of a new model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20452558" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : What is the best method for brain protection in surgery of the aortic arch? Selective antegrade cerebral perfusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31006001" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Antegrade selective cerebral perfusion reduced in-hospital mortality and permanent focal neurological deficit in patients with elective aortic arch surgery†.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1530810" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Selective cerebral perfusion during operation for aneurysms of the aortic arch: a reassessment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9895058" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Oxygen delivery during retrograde cerebral perfusion in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11216751" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Deep hypothermic circulatory arrest: II. Changes in electroencephalogram and evoked potentials during rewarming.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19372313" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Optimal perfusion during cardiopulmonary bypass: an evidence-based approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16790619" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Cardiopulmonary bypass management and neurologic outcomes: an evidence-based appraisal of current practices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16524149" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Update on pediatric perfusion practice in North America: 2005 survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Deep hypothermic circulatory arrest
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26706792" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Severity and Duration of Metabolic Acidosis After Deep Hypothermic Circulatory Arrest for Thoracic Aortic Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27397449" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Sodium bicarbonate use and the risk of hypernatremia in thoracic aortic surgical patients with metabolic acidosis following deep hypothermic circulatory arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27474330" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Comparison of Two Different Red Blood Cell Transfusion Thresholds on Short-Term Clinical Outcomes of Patients Undergoing Aortic Surgery With Deep Hypothermic Circulatory Arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30009645" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Effects of anesthesia on cerebral blood flow, metabolism, and neuroprotection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23644730" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Does the use of thiopental provide added cerebral protection during deep hypothermic circulatory arrest?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8853079" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Consequences of electroencephalographic-suppressive doses of propofol in conjunction with deep hypothermic circulatory arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25005856" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Pulmonary endarterectomy: Part II. Operation, anesthetic management, and postoperative care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30686656" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Perioperative Management of Pulmonary Endarterectomy-Perspective from the UK National Health Service.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23657546" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Intraoperative neuroprotective drugs without beneficial effects? Results of the German Registry for Acute Aortic Dissection Type A (GERAADA).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12358961" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Pharmacological agents as cerebral protectants during deep hypothermic circulatory arrest in adult thoracic aortic surgery. A survey of current practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21835900" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20472472" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Perioperative management of deep hypothermic circulatory arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29576107" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Steroids in cardiac surgery: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11772792" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11823666" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Postoperative hyperthermia is associated with cognitive dysfunction after coronary artery bypass graft surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15333386" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Prevention of cerebral hyperthermia during cardiac surgery by limiting on-bypass rewarming in combination with post-bypass body surface warming: a feasibility study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17532957" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Reliability of temperatures measured at standard monitoring sites as an index of brain temperature during deep hypothermic cardiopulmonary bypass conducted for thoracic aortic reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25590836" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Potentially modifiable risk factors for acute kidney injury after surgery on the thoracic aorta: a propensity score matched case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22269725" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Risk factors for perioperative acute kidney injury after adult cardiac surgery: role of perioperative management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18023682" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : RIFLE criteria for acute kidney injury in aortic arch surgery.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
